[
    {
        "pmid": "40819079",
        "title": "Impact of an optimized care model for advanced HIV disease: a non-randomized cluster study in Malawi.",
        "abstract": "Despite significant advance HIV diagnosis access ART many patient still present advanced HIV disease AHD assessed effect optimized AHD care package screening diagnosis opportunistic disease among client enrolled AHD care nonrandomized cluster design conducted using hubandspoke model Twentytwo health facilities including hub facility eight hub sites associated spoke facility 14 spoke sites purposively selected intervention site IS across three district Malawi optimized AHD package implemented included enhanced CD4 testing tuberculosis TB cryptococcal antigen CrAg screening appropriate treatment opportunistic disease delivered hubandspoke model Thirteen nonintervention site NIS five hub eight spoke sites chosen four district implement intervention matched based ruralurban setting health facility types abstracted individuallevel data routine clinical record client meeting World Health Organizations definition AHD June December 2021 963 patient AHD 574 seen IS 426 NIS showed higher proportion AHD client identified 443 vs 368 p  0020 increased screening child five year old 71 vs 27 p  0004 Additionally diagnosed case stage 3 4 disease 476 vs 405 P  0029 Patients seen significantly likely receive TB symptom screening Adjusted Relative Risk ARR 113 95 Confidence Interval CI 106121 urine lateral flow lipoarabinomannan test administration ARR 194 95 CI 118320 TB diagnosis ARR 264 95 CI 147475 Screening neurological sign also improved ARR 107 95 CI 102113 diagnosis cryptococcal meningitis ARR 428 95 CI 1581170 compared NIS difference retention mortality care patient twelve month followup NIS study underscore vital role improving screening diagnostic effort advanced HIV disease AHD notably targeting AHDrelated opportunistic infections including TB Cryptococcal diseases Word count 4832 words excluding references",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819079/",
        "source_type": "Global"
    },
    {
        "pmid": "40817574",
        "title": "Successful Treatment of Multidrug-Resistant Tuberculous Meningitis in a Young Chinese Woman: A Case Study From Japan.",
        "abstract": "BACKGROUND Multidrugresistant tuberculosis MDRTB continues pose serious public health challenge especially associated tuberculous meningitis TBM complicates treatment due need central nervous system CNS penetration nonoral administration routes case report describes 24yearold woman MDR pulmonary tuberculosis tuberculous meningitis TBM successfully treated combination pyrazinamide levofloxacin cycloserine linezolid CASE REPORT previously healthy 24yearold woman Jilin Province China presented fever headache impaired consciousness Chest computed tomography CT showed centrilobular nodule treeinbud appearances magnetic resonance imaging MRI revealed basal meningeal enhancement tuberculomas Acidfast bacillus AFB detected smear microscopy cerebrospinal fluid CSF culture confirmed Mycobacterium tuberculosis Drug susceptibility testing confirmed MDRTB Due impaired consciousness treatment regimen selected based CNS penetration enteral administration compatibility combination pyrazinamide levofloxacin cycloserine linezolid administered 18 months Bedaquiline pretomanid used due insufficient CNS penetration data time limited availability Japan patient required prolonged mechanical ventilation discharged minimally conscious state 541 days CONCLUSIONS case highlight importance individualized drug selection MDRTB CNS involvement managing tuberculosis especially lowincidence countries epidemiological background patients country origin also considered Early diagnosis appropriate drug selection critical patients survival despite severe neurological sequelae",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817574/",
        "source_type": "Global"
    },
    {
        "pmid": "40817073",
        "title": "ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.",
        "abstract": "standard care SOC treatment drugsusceptible pulmonary tuberculosis DSTB consists isoniazid rifampicin pyrazinamide ethambutol HRZE New treatment regimen option DSTB needed HRZE long duration 6 months associated frequent adverse events unforgiving adherence lapses complicated rifamycinbased drugdrug interactions recent resurgence TB drug development particularly context drugresistant TB offer promise additional regimen person DSTB provided sufficiently effective welltolerated spotlight wave 1 RADTB platform trial ACTG A5409 NCT06192160 investigate new chemical entity treatment DSTB wave 1 RADTB platform adult participant initiating treatment DSTB randomized SOC HRZE Arm 1 one five experimental arm 8week intensive phase experimental treatment arm consist bedaquiline pretomanid backbone BPa combination one three oxazolidinones Arm 2 study linezolid BPaL dose 600 mg daily Arms 3A 3B study TBI223 1200 mg 2400 mg daily respectively Arms 4A 4B study sutezolid 800 mg 1600 mg daily respectively primary efficacy objective compare sputum culture time positivity TTP slope first 6 week treatment experimental treatment arm SOC primary safety objective compare new Grade 3 higher adverse event first 8 week treatment experimental treatment arm SOC intensive phase participant receive standard isoniazid rifampicin HR continuation phase 18 weeks Participants followed 52 week TB treatment initiation assess longterm outcomes Wave 1 RADTB platform aim identify optimal oxazolidinones regard efficacy safety combine BPa backbone treatment DSTB Subsequent wave platform trial may add fourth drug regimen study new diarylquinolines substitute bedaquiline study novel agent TB drug classes ClinicalTrialsgov NCT06192160  Registered January 5 2024",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817073/",
        "source_type": "Global"
    },
    {
        "pmid": "40816540",
        "title": "Characteristics and In-Hospital Outcomes of Clinically Diagnosed Tuberculosis Patients in a High-Burden Setting: A Five-Year Retrospective Analysis.",
        "abstract": "2016 National TB Prevalence Survey revealed TB prevalence 25 time higher routine surveillance indicated half patient receiving treatment missing national registry Clinically diagnosed tuberculosis CDTB duly recognized national TB guideline microbiological confirmation unattainable remains understudied despite relevance TB diagnostic surveillance program retrospective study analyzed 1187 hospitalized CDTB patient 20152019 Philippine tertiary hospital Statistical analysis identified mortality predictor via binary logistic regression p005 significant Patients mean age 472±173 years 70 male faced significant resource constraints 73 received GeneXpert testing 527 extrapulmonary TB case lacked required imaging Advancing age reduced improvement likelihood OR09889year 95 CI 0981509963 p0003 Pulmonary TB decreased improvement odds 60 OR040 95 CI 023068 p0001 Respiratory failure depicts disease severity patient supplemental oxygen OR060 95 CI 040089 p0011 mechanical ventilation OR014 95 CI 008025 p0001 reduced improvement 40 86 respectively Conversely incentive spirometry OR359 95 CI 1191086 p0024 surgical intervention OR310 95 CI 184523 p0001 tripled improvement odds Age pulmonary TB respiratory failure predict mortality hospitalized CDTB patients Incentive spirometry surgery significantly improve outcomes Findings provide input Philippine Acceleration Action Plan TB PAAPTB 2023  2025 scale pulmonary rehabilitation surgical pathways address diagnostic gap imaging GeneXpert integrate screening povertyalleviation program DSWD4Ps",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816540/",
        "source_type": "Global"
    },
    {
        "pmid": "40815535",
        "title": "Undetectable HIV-1 viral load among virally suppressed people living with HIV: implications for Undetectable equals Untransmittable (U=U) in resource-limited settings using dried spot testing.",
        "abstract": "UndetectableUntransmittable UU campaign grounded strong scientific evidence affirms people living HIV PLHIV undetectable viral load VL defined ≤50 copy per milliliter cmL 200 cmL HIV RNA transmit HIV sexual partners resourcelimited settings VL commonly measured using dried blood spot DBS testing higher limit detection 5501000 cmL report proportion PLHIV VL 1000 cmL also VL 200 cmL ≤50 cmL inform interpretation DBS VL result UU analyzed data 13 crosssectional nationally representative survey 20152019 including PLHIV aged 1559 year receiving antiretroviral therapy ART valid plasma VL results estimated proportion participant VL 200 cmL ≤50 cmL among VL 1000 cmL overall among ART ≥12 month using survey weights Among 16533 PLHIV across 13 countries 873 VL 1000 cmL PLHIV VL 1000 cmL 954 VL 200 cmL 849 VL ≤50 cmL Among ART ≥12 months 966 VL 200 cmL 874 VL ≤50 cml PLHIV VL 1000 cmL VL 200 cmL ≤50 cmL indicating risk sexual HIV transmission finding provide evidence setting relying DBS VL testing PLHIV VL 1000 cmL likely fall 200 cmL undetectable based assays lower limit detection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815535/",
        "source_type": "Global"
    },
    {
        "pmid": "40814737",
        "title": "Silver-loaded hollow copper sulfide particles for antibacterial therapy.",
        "abstract": "misuse antibiotic accelerated spread antibiotic resistance AR making major global health threat Drugresistant bacteria iMycobacterium tuberculosisi iM tbi iStaphylococcus aureusi iS aureusi iEscherichia colii iE colii iPseudomonas aeruginosai iP aeruginosai continue cause severe infection worldwide underscore need alternative antibacterial strategies Photothermal therapy PTT appealing antibacterial approach excellent biocompatibility ability overcome AR however effectiveness often limited heat resistance bacteria study stepwise preparation method employed hollow copper sulfide CuS structure first synthesized using templating method followed reduction silver nanoparticles Ag NPs surface obtain CuSAg hybrid nanostructure iIn vitroi iBacillus CalmetteGuérini BCG selected model iM tbi antibacterial activity testing Briefly BCG treated 002 mg mLsup1sup CuSAg followed exposure 808 nm laser irradiation 6 minutes incubated 37 °C 24 hours achieving antibacterial rate 948 Additionally iE colii iS aureusi subjected condition incubated 37 °C 1 hour achieving antibacterial rate 335 494 respectively high 102 mg mLsup1sup concentration CuSAg exhibited 100 antibacterial efficacy BCG iE colii iS aureusi iP aeruginosai Overall result demonstrate CuSAg effectively combine controllable photothermal therapeutic property CuS antibacterial activity Ag nanoparticles resulting potent antimycobacterial broadspectrum antibacterial effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814737/",
        "source_type": "Global"
    },
    {
        "pmid": "40814508",
        "title": "Comparative analysis of tuberculosis drug consumption data in public and private sectors across selected districts of Madhya Pradesh.",
        "abstract": "study aimed compare drug consumption rate public private healthcare sector 2018 2022 Tikamgarh Datia Niwari district Madhya Pradesh communitybased survey methodology employed alongside analysis program data evaluation antiTB drug sale utilization healthcare sectors Data collected district hospital public private sectors Hospital record pharmacy log reviewed assess antiTB medication consumption rate 2018 2022 Sputum sample patient chest symptom history antiTB treatment tested using XpertRifTrueNat analysis compared drug consumption rate based hospital record calculated according pharmacy sale data mean patient month public sector 10354 months SD  8780 significantly exceeded private sector 4820 months SD  9519 Public sector drug sale varied Tikamgarh declining sharply 38304 patient month 2018 8810 2019 Datia remained stable private sector particularly Datia peaked 30238 patient month 2020 Oneway ANOVA showed significant difference sector patient month iFi  274 iPi  109 Linear regression identified patient month significant predictor calculated patient estimate  016529 iPi  001 Aligning drug consumption pattern across healthcare sector vital effective tuberculosis management Addressing disparity drug consumption rate crucial accurate TB incidence estimates",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814508/",
        "source_type": "Global"
    },
    {
        "pmid": "40814469",
        "title": "Rare cause of extrapulmonary tuberculosis in an immunocompetent elderly patient.",
        "abstract": "Tubercular hepatic abscess geriatric population rare often misdiagnosed frequently leading delayed presumptive treatment based tissue biopsy findings Early accurate diagnosis using advanced diagnostic tool crucial improving prognosis present case 65yearold immunocompetent male reported threemonth history fever one month right hypochondrial pain Diagnosis tubercular hepatic abscess confirmed using cartridgebased nucleic acid amplification test CBNAAT isolated iMycobacterium tuberculosisi sensitive rifampicin patient treated successfully standard antitubercular regimen Although case tubercular liver abscess documented using CBNAAT direct identification pu sample rare Misidentification abscess bacterial neoplastic often result inappropriate treatment increasing risk mortality case highlight importance early diagnosis prompt initiation appropriate therapy improve outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814469/",
        "source_type": "Global"
    },
    {
        "pmid": "40814457",
        "title": "Estimate of TB incidence and a critical analysis of programmatic data of TB score from Sub national Certification survey of district Niwari, M.P., India.",
        "abstract": "India accounted 26 global tuberculosis TB burden 2023 27 lakh case reported 89 treatment coverage Madhya Pradesh highburden state reported 28299 case 2023 Government India aim eliminate TB 2025 Strategic National Campaign SNC emphasizing surveillance early diagnosis comprehensive care study evaluates TB management trend Niwari district Madhya Pradesh tribal region 2018 2022 estimate TB incidence validate claim TBfree status SNC surveys analyze TB score trend Niwari district retrospective crosssectional study utilized data National Tuberculosis Elimination Programme NTEP including record District Tuberculosis Officer DTO treatment cards laboratory registers Nikshay portal Seven TB score parameter analyzed notification HIV screening UDST treatment success TB incidence calculated per 100000 population five year 20182022 Ethical clearance obtained TB notification improved 596 833 97 HIV screening 2022 UDST peaked 1125 2020 Treatment success rate ranged 806 876 However Nikshay Poshan Yojana beneficiary payment declined 875 2021 494 2022 TB incidence fluctuated 129 per lakh 2018 143 per lakh 2022 reflecting improved detection postCOVID19 Verified data closely matched reported data 2022 Niwari district made significant progress TB management particularly notification HIV screening challenge persist sustaining financial support addressing operational inefficiencies Continued community engagement advocacy SNC round crucial achieving TB elimination 2025",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814457/",
        "source_type": "Global"
    },
    {
        "pmid": "40814323",
        "title": "Hemorrhagic pericardial effusion 6 months following atrial septal defect device closure: Has it eroded?",
        "abstract": "Transcatheter closure atrial septal defect ASD preferred modality treatment Pericardial effusion occurring late ASD device closure extremely rare devicerelated erosion likely possibility describe 41yearold male underwent ASD device closure 32mm Amplatzer Septal Occluder device developed cardiac tamponade 6 month procedure Extensive investigation reveal evidence erosion Given endemicity tuberculosis India exudative pericardial effusion positive tuberculin skin test presence matted mediastinal lymph nodes patient started antitubercular therapy reaccumulation pericardial fluid subsequent followups conclude hemorrhagic pericardial effusion following device closure ASD secondary erosions ruling device erosion etiology pericardial effusion carefully searched for",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814323/",
        "source_type": "Global"
    },
    {
        "pmid": "40814267",
        "title": "Discovery of Rigid Linker-Based IRAK4 PROTACs with Improved Metabolic Stability for the Treatment of Inflammatory Diseases.",
        "abstract": "Interleukin1 receptorassociated kinase 4 IRAK4 promising therapeutic target inflammatory diseases However solely inhibiting IRAK4 kinase activity fails fully block inflammatory signaling resulting limited efficacy Herein describe design synthesis novel IRAK4 degrader based proteolysistargeting chimera PROTAC strategy preferred compound bFIP22b effectively degraded cellular IRAK4 DCsub50sub 32 nM 115fold higher lead compound bDE5b Mechanistically bFIP22b induces ubiquitinproteasome system forming IRAK4bFIP22bCRBN ternary complex thereby potently blocking IRAK4mediated NFκB MAPK signaling pathways Concurrently bFIP22b demonstrated favorable safety profile excellent metabolic stability eg 180fold longer halflife lead compound bDE5b Furthermore bFIP22b exhibited significant therapeutic efficacy 24dinitrochlorobenzeneinduced atopic dermatitis mouse model summary bFIP22b represents candidate IRAK4 degrader alternative targeting strategy advanced drug development",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814267/",
        "source_type": "Global"
    },
    {
        "pmid": "40814110",
        "title": "Mid- to short-term efficacy of Uniportal Video-Assisted Thoracoscopic Surgery in the treatment of thoracic spinal tuberculosis.",
        "abstract": "Surgical treatment thoracic spine tuberculosis using traditional procedure often challenged high trauma slow recovery study aimed investigate short mediumterm efficacy safety Uniportal VideoAssisted Thoracoscopic Surgery minimally invasive singleport thoracoscopy combined posterior internal fixation treatment thoracic spinal tuberculosis Nineteen patient thoracic spinal tuberculosis 15 men four women mean age 52 years retrospectively included patient underwent singleport thoracoscopic lesion removal intervertebral implant fusion combined posterior internal fixation Surgical time intraoperative bleeding volume hospitalization time complication recorded rate bone fusion correction kyphosis angle assessed using imaging followup period 612 months patient achieved postoperative bone fusion without serious complications average operative time 14958 min 75212 min average intraoperative bleeding volume 21053 mL 50600 mL average hospital stay 1558 229 d mean thoracic kyphosis angle improved 2333° preoperatively 1900° final followup Singleport thoracoscopic technique combined posterior internal fixation effectively remove thoracic tuberculosis focus correct kyphosis deformity Moreover advantage less trauma quicker recovery significant short mediumterm efficacy making feasible minimally invasive surgical procedure treating thoracic spinal tuberculosis However optimizing instrumentation design expanding sample size future necessary validate longterm effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814110/",
        "source_type": "Global"
    },
    {
        "pmid": "40812722",
        "title": "Association between Allergic Bronchopulmonary Aspergillosis or Aspergillus sensitization and Tuberculosis: A Systematic Review of 607 cases.",
        "abstract": "Although allergic bronchopulmonary aspergillosis ABPA classically described asthma cystic fibrosis pulmonary tuberculosis PTB posttubercular lung disease PTLD reported likely predisposing factor  however reviewed systematically aimed achieve current systematic review screened available literature PubMed Embase SCOPUS Web Science database study reporting association ABPA PTB beginning time June 30 2023 collated data association ABPA tuberculosis 1176 article identified initial search 60 article 27 original article 33 case reports included final analysis  Four pattern described ABPA patient previous TB 151 249 coexistent ABPA TB 16 26  Aspergillus sensitization patient prior current TB 91 ∼15 ABPA misdiagnosed TB 349 575 significant heterogeneity diagnostic criterion used ABPA andpulmonary TB limited individual data could extractedobservations were 1 Central bronchiectasis 248 cavity 196 fungal ball 109 mucus plughigh attenuation mucus HAM 76 centrilobular nodule 65 common radiographic abnormalities 2 964 received steroids11 received antifungal mostly relapse inadequate response 3 Adequate treatment response noted limited cohort reported ABPA commonly misdiagnosed TB Aspergillus sensitization ABPA develop patient prior TB However significant heterogeneity diagnostic criterion limit generalizability Future welldesigned study required confirm associations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812722/",
        "source_type": "Global"
    },
    {
        "pmid": "40812685",
        "title": "Revolutionizing non-tuberculous mycobacteria research: Advances in molecular diagnostics, phylogenetics, and clinical management.",
        "abstract": "Nontuberculous mycobacteria NTM emerged one significant opportunistic pathogens presenting challenge diagnosis treatment due diverse species intrinsic drug resistance rising global incidence Advanced molecular techniques including nextgeneration sequencing NGS polymerase chain reaction PCR matrixassisted laser desorption ionizationtime flight mass spectrometry MALDITOF MS significantly improved accuracy speed specie identification enabling precise timely diagnosis Phylogenetic study utilizing wholegenome sequencing WGS deepened understanding NTM evolution genetic diversity pathogenicity refining specie classification epidemiological tracking Despite advancements key challenge remain including lack standardized diagnostic criteria prolonged treatment durations emerging antimicrobial resistance Integrating multiomic technologies artificial intelligencedriven diagnostics innovative therapeutic strategy hold great promise overcoming barriers Future research must focus translating molecular discovery clinical application enhance NTM diagnosis treatment surveillance leveraging advancements medical community improve patient outcomes reduce global burden NTM infections advance precision medicine fight challenging pathogens review highlight recent molecular diagnostics phylogenetics clinical management breakthrough transforming NTM research patient care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812685/",
        "source_type": "Global"
    },
    {
        "pmid": "40812596",
        "title": "Pulmonary drug delivery of clofazimine: A route of administration and pharmacokinetics guided repositioning strategy against drug resistant tuberculosis informed by use for other disease indications.",
        "abstract": "Current oral therapeutic regime Clofazimine CFZ tuberculosis treatment limited poor pharmacokinetics long tsub12sub especially exposurerelated systemic toxicity review critically evaluates pulmonary administration targeted delivery approach reduce dose improve therapeutic efficacy primarily antileprotic indication CFZ evolved treatment multidrugresistant tuberculosis MDRTB nontuberculous mycobacterial NTM diseases smallcell lung cancer programmed cell death protein 1 PD1 cytotoxic Tlymphocyteassociated antigen 4 CTLA4 cancer patients Despite broadspectrum activity clinical effectiveness constrained poor physicochemical pharmacokinetic properties Due high lipophilicity orally administered CFZ high volume distribution 1470 L tends accumulate fatty tissues resulting long time reach steady state concentrations subtherapeutic drug level infection site increased risk systemic toxicity triggering drug resistance time Although novel delivery system administered oral route also explored extensively inadequate address concern sustained systemic exposure Pulmonary delivery enables direct deposition diseased site provides higher local concentration reduces offtarget effects Poor solubility high lipophilicity principal biopharmaceutical disadvantage CFZ oral formulation development However property advantageous pulmonary delivery facilitating prolonged lung retention reduced dosing frequency review evaluates current advantage challenge CFZ inhalation versus oral formulations discusses pharmacokinetic profiles explores pulmonary macrophage uptake strategy optimize tuberculosis treatment outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812596/",
        "source_type": "Global"
    },
    {
        "pmid": "40811999",
        "title": "Mechanisms of bacterial heme uptake and degradation: Diverse strategies for ring opening.",
        "abstract": "Iron acquisition bacterial pathogen critical survival virulence within host Heme represents viable source iron pathogen overcome limited iron availability establish infection past decade several new paradigm bacterial heme degradation identified Herein briefly discus mechanism bacterial pathogen acquire utilize heme particular focus three major class hemedegrading enzymes canonical heme oxygenase HO noncanonical HOs class C radical SAM methyl transferases canonical HO enzyme typified gramnegative pathogen Pseudomonas aeruginosa Neisseriae meningitidis shown structurally mechanistically similar eukaryotic HO enzymes contrast noncanonical HOs grampositive pathogen Staphylococcus aureus Mycobacterium tuberculosis distinct ferredoxinlike structural fold extreme heme ruffling give rise alternate heme metabolites Enteric pathogen E coli O157H7 Vibrio cholera encode hemedependent radical SAM methyl transferase open porphyrin ring oxygenindependent manner essential anoxic environment gut three class hemedegrading enzyme provide advantage survival within host also yielding metabolite play role bacterial adaptation virulence Therefore complete understanding distinct mechanism heme degradation role unique heme metabolite provide platform development antibacterial strategy targeting heme catabolism",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811999/",
        "source_type": "Global"
    },
    {
        "pmid": "40809674",
        "title": "Improving tuberculosis infection treatment completion among pregnant and postpartum women.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809674/",
        "source_type": "Global"
    },
    {
        "pmid": "40809215",
        "title": "Synchronous percutaneous microwave ablation combined with percutaneous biopsy for highly suspected malignant pulmonary nodules: a retrospective study.",
        "abstract": "still lack study optimal sequence treatment microwave ablation MWA combined percutaneous biopsy PB treatment highly suspected malignant pulmonary nodule PNs study aimed investigate feasibility safety efficacy computed tomography CTguided simultaneous MWA combined PB treatment highly suspected malignant PNs discus influence sequential order MWA PB treatment outcome January 2021 December 2024 91 patient single highly suspected malignant PNs underwent synchronous MWA combined PB total 56 patient group underwent synchronous MWA followed PB MWAfirst group 35 case group B underwent synchronous PB followed MWA PBfirst group technical success pathologically positive diagnosis rate complications efficacy two group compared difference technical success rate 100 ivsi 971 positive pathologic diagnosis rate 804 ivsi 886 group group B statistically significant P005 common complication included pneumothorax intrapulmonary hemorrhage hemoptysis pleural effusion incidence intrapulmonary hemorrhage significantly lower group group B 196 ivsi 428 P005 median followup time 180 months local control rate 988 complete ablation CA rate 566 Synchronous MWA combined PB safe effective strategy MWA followed PB could reduce impact intrapulmonary hemorrhage ablation outcome alternative treatment highly suspected malignant PN",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809215/",
        "source_type": "Global"
    },
    {
        "pmid": "40808947",
        "title": "BCG and beyond: unlocking new frontiers in TB vaccine development.",
        "abstract": "Please confirm Frontiers AI generated AltText accurate visual description Figures Figure Alttext proposal replace figure caption visible article wish make changes kindly provide exact revised AltText would like use ensuring wordcount remains approximately 100 word best accessibility results information AltText found hereWith 10 million new case 16 million death annually tuberculosis TB continues significant worldwide healthburden assist curbing spread TB centuryold BCG liveattenuated vaccine licensed TB vaccine used humans However BCGs limited efficacy poor antigenicity adult evoked need design new vaccine TB limited parameter availability potent antigens consequence imperative study iMycobacterium tuberculosisi iMtbispecific antigen provide stronger immune response included vaccine candidates review aim concentrate progress current vaccinecandidates undergoing preclinical clinicalstudies Moreover pathogen genetics host play essential role finetuning immuneresponse susceptibility TB past 50 years systematic approach treating TB patient overlooked factor like pharmacokinetics immuneresponse treatment duration Henceforth review highlight precision medicineguided approach considering geneticmakeup host immunity could influence clinical management choices consolidated review shed light advancement vaccinecandidates harnessed prophylactic development TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808947/",
        "source_type": "Global"
    },
    {
        "pmid": "40808944",
        "title": "Experimental validation of cuproptosis-associated molecular signatures and their immunological implications in pulmonary tuberculosis.",
        "abstract": "pathogenic mechanism underlying iMycobacterium tuberculosisi MTB remains elusive posing challenge diagnosis treatment Cuproptosis newly identified mechanism cell death study explores role cuproptosisrelated gene CRGs pulmonary tuberculosis PTB uncover potential diagnostic biomarkers therapeutic targets Differentially expressed gene DEG analysis weighted gene coexpression network analysis WGCNA carried using GSE83456 dataset PTBassociated DEGs intersected CRGs identify PTBrelated CRGs Subsequent analysis included functional enrichment gene interaction proteinprotein interaction PPI network construction Hub CRGs screened via least absolute shrinkage selection operator LASSO regression random forest RF algorithms Diagnostic model subsequently constructed validated association immune cell infiltration pathway identified hub gene evaluated singlesample gene set enrichment analysis ssGSEA CIBERSORT Hub gene expression validated GSE42834 GSE89403 datasets well RTqPCR Western blot WB PTB extrapulmonary tuberculosis EPTB patients GSE89403 dataset gene expression profiling leveraged analyze differential expression hub gene dynamic change treatment Seven PTBrelated CRGs significantly upregulated significantly upregulated among ASPHD2 GK GCH1 identified hub genes gene exhibited high expression level patient PTB EPTB marked reduction observed following treatment Notable alteration immune cell infiltration immune function PTB patient closely related hub genes suggesting activation innate immune response suppression adaptive immune function cuproptosis hub gene ASPHD2 GK GCH1 influence pathogenesis PTB possibly serve novel diagnostic biomarkers therapeutic targets",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808944/",
        "source_type": "Global"
    },
    {
        "pmid": "40808635",
        "title": "Studying intrapulmonary pharmacokinetics for tuberculosis treatment: a systematic review of methodology.",
        "abstract": "Drug concentration site disease pulmonary tuberculosis TB remain limitedly available adequate exposure antiTB drug lung required sterilization lesions Intrapulmonary concentration data could benefit TB treatment optimization conducted systematic review identify method used sampling quantifying describing predicting intrapulmonary pharmacokinetics antiTB drug humans Two systematic search strategy conducted database Embase PubMed last searched 18 July 2024 total 253 study identified applied method classified three different categories i sampling techniques ii quantitative analysis iii modelling methods type pulmonary disease included search Sputum sampling reported sampling method nine studies tissue biopsy 51 bronchoalveolar lavage 115 bronchoscopic microsampling eight bronchoabsorption one microdialysis 12 studies LCMSMS gold standard drug quantification biological samples used 67 studies quantification method included positron emission tomography reported 12 study matrixassisted laser desorption ionization mass spectrometry lung tissue three studies prediction description preclinical intrapulmonary concentration data population pharmacokinetic modelling reported 32 study physiologically based pharmacokinetic modelling 35 studies Many identified method associated considerable limitation including invasiveness complexity cost lack standardization importantly method choice must provide adequate representation site disease pharmacokinetics Determining best approach studying intrapulmonary pharmacokinetics involves careful consideration factors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808635/",
        "source_type": "Global"
    },
    {
        "pmid": "40808616",
        "title": "Ti<sub>3</sub>C<sub>2</sub>O<sub>2</sub> MXene as a dual-action modulator of inflammatory and tuberculosis signaling: structural and <i>in vitro</i> insights.",
        "abstract": "growing threat antimicrobial resistance tuberculosis TB necessitates innovative therapeutic capable modulating infection host immune responses study report dual antitubercular antiinflammatory activity oxygenfunctionalized Tisub3subCsub2subOsub2sub MXene twodimensional nanomaterial synthesized iviai selective HF etching Tisub3subAlCsub2sub followed ethanolassisted delamination Structural characterization XRD Raman spectroscopy confirmed successful conversion MXene phase increased interlayer spacing 987 Å SEM TEM analysis revealed uniform sheetlike morphology AFM confirmed fewlayer thickness ∼15 nm Biological assay using lipopolysaccharide LPSstimulated murine macrophage cell line RAW 2647 macrophage demonstrated significant downregulation proinflammatory mediators inducible nitric oxide synthase iNOS Tumor necrosis factor TNFα Interleukin6 IL6with ICsub50sub value 232 261 216 μg mLsup1sup respectively Western blot analysis validated suppression inflammatory pathway protein level parallel Tisub3subCsub2subOsub2sub exhibited robust antitubercular activity iMycobacterium tuberculosisi H37Rv achieving complete inhibition 40 μg mLsup1sup Computational study revealed strong specific interaction Tisub3subCsub2subOsub2sub TB inflammatory target protein PDB ID 5V3Y forming stable hydrogen bond His185 Gln186 Asp219 Molecular dynamic simulation 3000 n confirmed highly stable proteinMXene complex RMSD 241 Å ΔiGisubbindsub 7854 kcal molsup1sup Comparative simulation streptomycin revealed weaker binding greater structural fluctuation ADMET prediction suggested favorable pharmacokinetic properties including high volume distribution low toxicity absence major cytochrome P450 cardiotoxic liabilities finding establish Tisub3subCsub2subOsub2sub MXene promising nanoplatform dualfunction immunomodulation antimicrobial therapy offering mechanistic structural insight bioactivity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808616/",
        "source_type": "Global"
    },
    {
        "pmid": "40807063",
        "title": "The Role of Obstructive Sleep Apnea in Pulmonary Hypertension Associated with Lung Diseases (Group 3 Pulmonary Hypertension): A Narrative Review.",
        "abstract": "Obstructive sleep apnea OSA could increase pulmonary artery pressure However clinical consequence vary mainly depending comorbidities Patients pulmonary hypertension associated lung disease World Health Organization WHO Group 3 pulmonary hypertension particularly vulnerable increase pulmonary artery pressure Managing pulmonary hypertension specific patient population present considerable challenge positive airway pressure therapy OSA shown promise improving pulmonary hemodynamics patient obesity hypoventilation syndrome chronic obstructive pulmonary disease evidence lacking similar improvement pulmonary disease hypoventilation disorders Furthermore pulmonaryarteryspecific therapy may carry risk clinical worsening group Weight management new pharmacotherapy together emerged crucial intervention demonstrating benefit OSA pulmonary hemodynamics reviewed key study provide insight influence OSA Group 3 pulmonary hypertension clinical management conditions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807063/",
        "source_type": "Global"
    },
    {
        "pmid": "40806949",
        "title": "Elevated Serum TNF-α/IL-1β Levels and Under-Nutrition Predict Early Mortality and Hospital Stay Burden in Pulmonary Tuberculosis.",
        "abstract": "bBackgroundObjectivesb Romania remains tuberculosis TB hotspot European Union yet hostderived factor poor outcome poorly characterised quantified circulating proinflammatory cytokine examined interplay behavioural risk factors nutritional status clinical course adult hospitalised pulmonary TB analysed 80 adult microbiologically confirmed pulmonary TB 40 respiratory symptom controls four TB patient 5 died hospitalisation within 10 day admission bMethodsb retrospective analytical casecontrol study conducted Constanța regional TB referral centre October 2020October 2023 Patients smear cultureconfirmed TB frequencymatched sex 10year age band BMI class culturenegative respiratory control 21 ratio patients serum interferonγ IFNγ interleukin1α IL1α interleukin1β IL1β tumournecrosisfactorα TNFα quantified within 24 h admission neutrophillymphocyte ratio NLR extracted full blood counts Independent predictor inhospital mortality identified multivariable logistic regression factor associated length stay LOS modelled quasiPoisson regression bResultsb median TNFα 241 pg mLsup1sup vs 162 pg mLsup1sup ipi  0009 IL1β 534 pg mLsup1sup vs 367 pg mLsup1sup ipi  0008 significantly higher TB case controls TNFα strongly correlated IL1β ρ  080 ipi  0001 NLR showed weak concordance multiplex cytokine patterns Among patient TB four early death 5 exhibited tripling TNFα 714 pg mLsup1sup doubling NLR 78 compared survivors 10 pg mLsup1sup rise TNFα independently increased odds inhospital death 18fold 95 CI 1130 ipi  002 LOS median 29 days unrelated smoking alcohol comorbidity load varied across BMI strata underweight 27 days normal weight 30 days overweight 23 day KruskalWallis ipi  003 multivariable analysis undernutrition BMI  185 kg msup2sup prolonged LOS 19 IRR 119 95 CI 105134 ipi  0004 independently disease severity bConclusionsb hyperTNFαIL1β systemic signature correlate early mortality Romanian pulmonary TB undernutrition dominant modifiable determinant prolonged hospitalisation Admission algorithm pair rapid TNFα testing systematic nutritional assessment could enable targeted hostdirected therapy trial optimise bed utilisation highburden settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806949/",
        "source_type": "Global"
    },
    {
        "pmid": "40806905",
        "title": "Willingness to Become a Living Kidney Donor to a Stranger Among Polish Health Care Professionals Employed in a Dialysis Center: A National Cross-Sectional Study.",
        "abstract": "bBackgroundb Kidney transplantation living donor considered beneficial form treatment endstage renal failure which addition providing patient better treatment results significantly improves quality life Understanding factor influence willingness donate kidney stranger critical promoting expanding living donor pool considering decision become altruistic kidney donor individual must evaluate multiple factors including identity recipient perceived level safety study aimed assess willingness dialysis center employee act living kidney donor stranger bMethodsb conducted crosssectional study February 2023 June 2024 among dialysis specialist across Poland study involved 1093 people doctors nurses study used survey questionnaire standardized tools bResultsb Nurses vs physicians advocated regulation unspecified living kidney donation Poland believe risk organ trafficking would donate kidney husbandwife friend accept kidney transplantation husbandwife likely donate kidney stranger Furthermore respondent accepted loved ones decision donate kidney stranger significantly willing donate kidney person themselves Perceived selfefficacy positively associated willingness donate kidney stranger bConclusionsb Less half healthcare professional supported unspecific living organ donation Poland nurse willing donate physicians factor supporting decision generally included knowledge organ donation transplantation lack fear organ trafficking attitude towards donation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806905/",
        "source_type": "Global"
    },
    {
        "pmid": "40806803",
        "title": "Evaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience.",
        "abstract": "bBackgroundb Secukinumab fully human monoclonal antibody target interleukin IL17A used treat axial spondyloarthritis axSpA psoriatic arthritis PsA Treating axSpA PsA challenging patient comorbidities multicenter retrospective study aimed evaluate efficacy safety secukinumab treatment patient axSpA PsA history tuberculosis multiple sclerosis MS congestive heart failure CHF bMethodsb study included 44 patient diagnosis axSpA PsA history tuberculosis MS CHF received secukinumab treatment 13 center country Erythrocyte sedimentation rate Creactive protein CRP Bath Ankylosing Spondylitis Disease Activity Index Ankylosing Spondylitis Disease Activity Score CRP visual analog scale Disease Activity Score28 CRP marker month 0 3 12 secukinumab treatment analyzed Alongside this tuberculosis MS CHF evaluated followup using clinical assessment imaging method chest radiographs brain magnetic resonance echocardiography bResultsb statistically significant improvement inflammatory marker disease activity score observed patient treated secukinumab reactivation patient history tuberculosis MS patients disease stable clinical radiological improvement observed one patient worsening CHF stage observed patient history CHF bConclusionsb regular clinical monitoring secukinumab may effective safe treatment option axSpA PsA patient history tuberculosis MS CHF",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806803/",
        "source_type": "Global"
    },
    {
        "pmid": "40805879",
        "title": "A Systematic Review of Tuberculosis Stigma Reduction Interventions.",
        "abstract": "Stigma associated tuberculosis TB continues undermine patient wellbeing treatment adherence public health goal objectives study aim systematically review literature identify synthesize TB stigma reduction intervention published 2015 2025 Following PRISMA guidelines conducted comprehensive literature search across PubMed Scopus Science Direct ProQuest Google Scholar Eligible study included qualitative quantitative mixedmethods design focused intervention related TBrelated stigma categorized study three groups 1 intervention development studies 2 TB treatment program stigma reduction outcomes 3 stigmaspecific interventions Data extraction quality appraisal conducted independently two reviewer using Mixed Methods Appraisal Tool MMAT total 15 study met inclusion criteria Five study focused codeveloping stigma interventions incorporated multilevel multicomponent strategy targeting internalized enacted anticipated intersectional stigma Two study assessed TB treatmentrelated intervention eg homebased care digital adherence tools incidental stigma reduction effects remaining seven study implemented stigmatargeted interventions including educational programs videobased therapy peerled support antiselfstigma toolkits Interventions addressed stigma across individual interpersonal institutional community policy levels review highlight evolution diversification TB stigma intervention past decade earlier intervention emphasized education support recent strategy increasingly integrate peer leadership digital platforms socioecological frameworks finding underscore need comprehensive contextually grounded intervention reflect lived experience people affected TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805879/",
        "source_type": "Global"
    },
    {
        "pmid": "40805128",
        "title": "Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study.",
        "abstract": "bBackgroundb Pseudoprogression known occur immunecheckpoint inhibitor ICI therapy brain metastasis complicate clinical decisionmaking Still incidence timing clinical presentation remain unclear retrospective cohort study melanoma nonsmall cell lung cancer brain metastasis patient conducted address this bMaterials Methodsb Brain metastasis patient showing progression MRI according response assessment neurooncology brain metastasis criterion starting ICI therapy included irrespective prior irradiation Lesions classified tumour progression TP pseudoprogression based threemonth radiological followup histopathology TP assigned progression shown three months Pseudoprogression assigned lesion showed stability partial complete response three months Nonclassified lesion new changed treatment followup bResultsb cohort 98 patient 233 lesion included 13year period 170 lesion considered nonclassified 41 22 lesion classified TP pseudoprogression respectively resulted lesion patientspecific incidence pseudoprogression 94 173 respectively Due large number lesion could classified case clinical practice reported incidence study likely underestimation seen minimum incidence rate Ten pseudoprogression 455 13 317 TP lesion previously irradiated Pseudoprogression occurred median 27 month starting ICI therapy clinical feature distinguishing patient TP pseudoprogression TP patient likely need dexamethasone neurological symptoms bConclusionsb Pseudoprogression lesionspecific incidence rate least 94 occurs median 27 month starting ICI therapy Severe neurological symptom requiring dexamethasone may clinical feature typical TP",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805128/",
        "source_type": "Global"
    },
    {
        "pmid": "40803739",
        "title": "ThiPhiSA: new pathways to TB prevention from community screening - a household-randomised controlled trial in KwaZulu-Natal, South Africa.",
        "abstract": "Tuberculosis TB remains leading cause infectious disease deaths particularly among people living HIV PWH Despite preventable TB preventive therapy TPT uptake low highburden region like South Africa new guideline expanded TPT eligibility introduced shorter effective regimen like 3 month weekly rifapentine isoniazid 3HP differentiated service delivery model HIV care proven effective increasing recognition decentralising TPT delivery may improve coverage completion study explores whether communitybased TPT delivery strategy enhance uptake completion TPT compared traditional clinicbased services conduct householdrandomised nonblinded controlled trial Persons eligible TPT recruited TB TRIAGETrial study communitybased household TB screening study Households containing least one person eligible TPT randomised 11 either communitybased TPT standardofcare clinic referral TPT enrolment participant provided 2week supply TPT community Participants randomised community arm receive entire course TPT single dispense 12 week 3HP 6 month isoniazid 3HP contraindicated Clinicarm participant referred local clinic remainder course TPT collect TPT refill clinicdetermined schedule primary outcome proportion participant complete course TPT Secondary outcome include overall adherence TPT predictor adherence TPT participant satisfaction assigned TPT delivery method adverse events study tool approved Human Sciences Research Councils Research Ethics Committee approval number 2251023 based Pretoria Gauteng South Africa well University Washington Institutional Review Board Study 00018448 Study finding shared community advisory group local stakeholder meetings relevant international local meetingsconferences peerreviewed publications NCT06214910 Date version 30 30 July 2024",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803739/",
        "source_type": "Global"
    },
    {
        "pmid": "40803725",
        "title": "Patient-cost studies on self-administered treatment (SAT) for drug-sensitive tuberculosis compared to facility-based directly observed treatment, short-course (DOTS): a protocol for a systematic review.",
        "abstract": "Many patient tuberculosis TB suffer huge economic burden even though TB service often provided free charge point care Costs create significant barriers hindering patients access TB treatment cost include direct medical cost such consultation fees direct nonmedical cost such transportation costs indirect cost such wage foregone systematic review aim synthesise best available evidence economic evaluation patientcost study selfadministered treatment SAT drugsensitive TB compared facilitybased directly observed treatment shortcourse FB DOTS globally conduct systematic review following Preferred Reporting Items Systematic Review MetaAnalysis Protocols guideline search PubMed Academic Search Complete Scopus CINAHL Plus EBSCO Google Scholar article published 2025 without date restrictions Eligible study must full partial cost analysis without effectiveness data economic evaluation conducted globally comparing SAT FB DOTS regarding TB patient costs Grey literature included Exclusion criterion include study reporting patient cost SAT FB DOTS noneconomic evaluation nonoriginal research Two independent reviewer conduct screening data extraction quality assessment quality assessment performed using Consolidated Health Economic Evaluation Reporting Standards statement Consensus Health Economic Criteria checklist ROBINSI tool Ethics approval required systematic review use individual patient data Instead use publicly available economic evaluation research studies Findings presented international national conference published openaccess peerreviewed journals CRD42024591221",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803725/",
        "source_type": "Global"
    },
    {
        "pmid": "40803711",
        "title": "Effects of Communication Strategies on Treatment Adherence and Success in Tuberculosis: A Systematic Review and Meta-Analysis.",
        "abstract": "Tuberculosis although curable present challenge related treatment adherence compromise treatment effectiveness Individual social structural barrier interfere patients ability properly follow therapeutic regimen thereby impacting treatment outcomes Given limitation conventional healthcare model relies primarily inperson consultation standard treatment protocol without additional adherence support technologies new approach explored improve patient outcomes study seek identify effective communication approach context identify effective communication strategy optimise treatment adherence improve therapeutic success patient diagnosed tuberculosis systematic review metaanalysis conducted included study available MEDLINE via PubMed EMBASE SCOPUS databases publication date January 2005 December 2024 primary outcome adherence success tuberculosis treatment systematic review included 17 study tuberculosis treatment adherence these 12 included metaanalysis adherence 8 treatment success effective strategy adherence community education 2 studies RR 025 95 CI 011056 video observed therapy VDOT 2 studies RR 029 95 CI 021040 combination electronic device SMS also showed positive result 3 studies RR 053 95 CI 037077 SMS alone 5 studies electronic device alone 3 studies effective treatment success combination electronic device SMS RR 031 95 CI 017055 community education RR 051 95 CI 040064 effective combination electronic device SMS community education effective strategy improving adherence therapeutic success tuberculosis treatment Isolated intervention SMS electronic technology show significant results Adapting approach local reality crucial optimising outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803711/",
        "source_type": "Global"
    },
    {
        "pmid": "40803230",
        "title": "The repurposed STAT3 inhibitor pyrimethamine controls mycobacterial infection-induced vascular permeability and mycobacterial burden.",
        "abstract": "Infectioninduced vascular pathology side effect immune response contact range pathogens Mycobacteria including Mycobacterium tuberculosis particularly adept coopting vascular leakiness survival mechanism shape host immune response impede delivery antibiotic site infection using zebrafishMycobacterium marinum infection model confirm critical role Signal transducer activator transcription 3 STAT3 mediating infectioninduced vascular permeability demonstrate ability FDAapproved drug atovaquone Mepron pyrimethamine Daraprim restore vascular barrier function without compromising innate immune control mycobacterial infection find additional antibiotic effect pyrimethamine M marinum M tuberculosis Together finding suggest pyrimethamine could used adjunctive therapy mycobacterial infection explain protective effect Daraprim prophylaxis tuberculosis diagnosis HIV positive populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803230/",
        "source_type": "Global"
    },
    {
        "pmid": "40803204",
        "title": "Ultra-sensitive urinary lipoarabinomannan (LAM) immunoassay for tuberculosis detection: a performance evaluation.",
        "abstract": "development rapid nonsputum test remains global priority accelerate Tuberculosis TB diagnosis treatment initiation WHOrecommended rapid diagnostic test RDT Alere Determine TB Lipoarabinomannan Ag AlereLAM suboptimal sensitivity laboratorybased electrochemiluminescence LAM assay EclLAM current sensitivity benchmark RDT development gold standard urinary LAM detection assessed diagnostic accuracy ultrasensitive Plasmonic Fluorlinked Immunosorbent LAM assay PFLISALAM compared Sputum Xpert MTBRIF sputum culture urine EclLAM developed evaluated assay performance PFLISALAM Two substudies conducted using banked urine samples 1 Preclinical study using 337 wellcharacterised urine sample cutoff determination initial evaluation performance PFLISALAM compared sputum Xpert MTBRIF culture 2 Diagnostic accuracy assessment study using 77 blinded sample evaluate performance PFLISALAM compared EclLAM versus microbiological reference standard MRS Xpert positive andor culture positive PFLISALAM limit detection LOD 084 ± 09 pgmL detecting purified LAM spiked urine preclinical study optimal assay cutoff determined 17 pgmL sensitivity PFLISALAM sputum Xpert MTBRIF compared culture 51 95 confidence interval CI 4359 62 95 CI 5370 specificity PFLISALAM Xpert MTBRIF 99 95 CI 96100 100 95 CI 100100 Combining PFLISALAM Xpert MTBRIF test data improved sensitivity 76 95 CI 6983 achieved diagnostic study sensitivity EclLAM PFLISALAM assay 42 95 CI 2759 73 95 CI 5685 specificity EclLAM PFLISALAM 95 95 CI 8599 98 95 CI 88100 better analytical diagnostic sensitivity compared EclLAM PFLISALAM better detect urinary LAM TBpositive cases PFLISALAM assay also demonstrated capability increase diagnostic value detecting urinary LAM complementing molecular tests achieving improved diagnostic outcome report external financial support conducting study",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803204/",
        "source_type": "Global"
    },
    {
        "pmid": "40802343",
        "title": "Trends and clusters of tuberculosis treatment interruption among people experiencing homelessness in Brazil: influence of individual, social and programmatic factors.",
        "abstract": "analyze temporal trend statelevel cluster tuberculosis treatment interruption indicator among homeless population Brazil ecological study treatment interruption among homeless people tuberculosis assessed 2015 2023 Joinpoint regression used trend analysis stratified sociodemographic epidemiological variables State cluster identified kmeans clustering analysis based socioeconomic programmatic indicators Tuberculosis treatment interruption increased among men average quarterly percent change  AQPC015 95 confidence interval  95CI 004029 individual aged 4059 year AQPC038 95CI 025053 tobacco user AQPC072 95CI 061082 beneficiary social program AQPC459 95CI 369602 without directly observed treatment AQPC049 95CI 039063 without HIV coinfection AQPC038 95CI 030051 North AQPC151 95CI 096221 Midwest AQPC083 95CI 017159 regions According cluster analysis cluster lowest treatment interruption rate low AIDS incidence better programmatic indicators Cluster B high poverty low level education income strong primary health care performance Cluster C stood higher human development better social indicators lower inequality Cluster concentrated worst outcomes higher treatment interruption greater inequality higher AIDS incidence weaker primary health care Socioeconomic programmatic inequality evident access attachment tuberculosis treatment among people experiencing homelessness Brazil",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802343/",
        "source_type": "Global"
    },
    {
        "pmid": "40801004",
        "title": "Molecular identification and antifungal susceptibility testing of <i>Aspergillus</i> species among patients with chronic pulmonary aspergillosis in Nigeria.",
        "abstract": "Triazole resistance iAspergillusi spp therapeutic implication managing chronic pulmonary aspergillosis CPA worldwide However antifungal susceptibility testing AFST routinely performed Nigeria country high CPA burden study aimed confirm identity iAspergillusi spp isolated patient CPA using molecular methods determine antifungal susceptibility profile ascertain phylogenetic relatedness study examined 47 iAspergillusi isolates sputum sample obtained prospective longitudinal study CPA prevalence among 141 consenting symptomatic tuberculosis patient Lagos Nigeria June 2021 May 2022 preliminary phenotypically identified iAspergillusi spp identified amplifying calmodulin gene performing AFST seven antifungal agent using Clinical Laboratory Standard Institute CLSI microdilution method well determining phylogenetic relatedness 51 patient met diagnostic criterion CPA included 30 590 male 21 410 female patient age range 1768 years Thirtysix 710 positive iAspergillusi cultures isolate initially identified phenotypically iA fumigatusi reidentified iA pseudonomiaei Phylogenetic analysis iA fumigatusi iA flavusi isolates suggested absence clonal transmission isolates susceptible tested antifungals Clinical iAspergillusi isolates azolenaïve patient CPA demonstrate triazole resistance Nonetheless AFST required patient longterm azole therapy systematic surveillance clinical environmental isolates recommended detect emergence azoleresistant phenotypes study underscore importance routine surveillance antifungal resistance detect occurrence resistance strain early clinical settings therapeutic implication patient harbouring resistant phenotypes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801004/",
        "source_type": "Global"
    },
    {
        "pmid": "40800027",
        "title": "Geospatial Distribution of Tuberculosis Incidence and Determinants of Tuberculosis Treatment Outcomes in Nzema East Municipality, Ghana.",
        "abstract": "Ghana seen notable rise tuberculosis TB case mired treatment outcomes However evidence suggests disparity incidence TB treatment outcome across country Nzema East Municipality specifically reported 6234 increase TB incidence 2023 compared 2022 study therefore aim determine geospatial distribution TB incidence predictor TB treatment outcome Nzema East Municipality study used retrospective cohort quantitative approach utilising health record 545 TB case 2018 2023 Nzema East Data processed Microsoft Excel analysed using ArcGIS Pro version 332 Joinpoint Regression Programme 520 STATA MP version 17 Morans index 003 ipi  0001 subdistricts least one settlement 226 TB case per square kilometre Significant TB hotspot identified populationdense community mining communities Overall successful TB treatment outcome 7670 significant decline successful TB treatment outcome 2018 end 2020 2023 ipi  003 ipi  0001 respectively least one followup lab aRR  043 95 CI  032 058 treatment supporter aRR  056 95 CI  040 079 lessens risk unsuccessful TB treatment outcome started TB treatment 2020 increase chance unsuccessful outcome aRR  197 95 CI  113 343 TB incidence Nzema East spatially dependent statistically significant higher incidence highly populated mining communities overall successful treatment outcome suboptimal demand targeted intervention mitigate menaces",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40800027/",
        "source_type": "Global"
    },
    {
        "pmid": "40799963",
        "title": "Sociodemographic and health-related factors associated with viral load non-suppression and body mass index in adults with depression symptoms receiving antiretroviral therapy in South African primary care: secondary analysis of randomised trial data.",
        "abstract": "Unsuppressed viral load antiretroviral therapy ART associated health decline HIV transmission overweight obese increase risk noncommunicable diseases increasing risk multimorbidity people living HIV ART effectiveness obesity shown affected socioeconomic psychological health related factors interrelationship South Africans living HIV well known secondary analysis data randomised controlled trial depression management 2002 adult receiving ART investigated effect sociodemographic characteristics comorbidities depression symptom Patient Health Questionnaire9 PHQ9 functional disability WHODAS20 AIDSrelated stigma ART adherence viral load nonsuppression viral load ≥1000 copiesml body mass index BMI baseline baseline change 12 month later using longitudinal mixed effect logistic linear regression models Potentially confounding covariates selected adjusted using least absolute shrinkage selection operator LASSO inference People viral load nonsuppression baseline likely male younger earn lower income Health characteristic associated viral load nonsuppression baseline previous tuberculosis ART less 6 month 10 years selfreported nonadherence ART Higher disability score ART duration 6 month 10 year baseline associated increasing likelihood viral load nonsuppression 12 month later Higher BMI baseline associated female married earning higher income hypertension history tuberculosis viral load nonsuppression BMI increased baseline followup younger age associated greater increase BMI 12 month later Depression symptom score stigma score associated viral load nonsuppression BMI Viral load nonsuppression associated lower BMI likely due effect HIVrelated illness Viral load nonsuppression BMI associated variety sociodemographic factors viral load nonsuppression also associated disability ART nonadherence finding together indicate subgroup people HIV need improved ART access adherence support Neither outcome associated severity depression symptom selfreported stigma ClinicalTrialsgov  NCT02407691  Pan African Clinical Trials Registry 201504001078347 South African National Clinical Trials Register SANCTR DOH2705155048 NHREC 4048",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799963/",
        "source_type": "Global"
    },
    {
        "pmid": "40799900",
        "title": "Laryngeal Tuberculosis Mimicking Laryngeal Carcinoma: A Case Report.",
        "abstract": "Laryngeal tuberculosis LTB rare form extrapulmonary tuberculosis clinically radiologically resemble laryngeal carcinoma leading potential misdiagnosis report case 53yearold man history chronic smoking known tuberculosis BCG vaccination presented progressive dyspnea dysphonia significant weight loss Laryngoscopy revealed ulcerative lesion involving anterior commissure right ventricular strip arytenoid fold epiglottis CT imaging suggested malignancy biopsy confirmed LTB pulmonary involvement patient responded favorably antituberculous therapy nearcomplete resolution two months case highlight diagnostic challenge differentiating LTB malignancy Awareness rare presentation essential especially tuberculosis TBendemic regions avoid unnecessary surgical intervention ensure prompt medical treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799900/",
        "source_type": "Global"
    },
    {
        "pmid": "40799783",
        "title": "Stool-Based Molecular Tuberculosis Treatment Monitoring: A Faster Means for Detecting Persistent Mycobacteria Compared to Phenotypic Culture.",
        "abstract": "Tuberculosis TB treatment monitoring hindered lack rapidly measured biomarker accurately predicts clinically relevant outcomes Symptom screening poorly correlate bacillary burden Although culture direct measure viable bacillary burden long turnaround time make clinically irrelevant TB treatment monitoring potential stoolbased quantitative polymerase chain reaction qPCR prospectively assessed among 231 participant age Eswatini Tanzania Mozambique microbiologically confirmed TB Stool qPCR result compared sputum culture persistent symptoms drug resistance World Health Organization TB outcomes Quantitative bacillary burden measured stool qPCR strongly correlated sputum culture baseline Spearman correlation iri subssub  079 iPi  001 Stool successfully collected 90 timepoints sputum collection decreased 50 end therapy Participants isoniazid rifampin resistance demonstrated decreased bacillary clearance sputum culture stool qPCR first 2 week treatment Participants remained culture positive 2 month slower decrease bacillary burden measured stool qPCR compared culture negative 2 months odds participant culture positive 2 month associated lower initial qPCR cycle threshold odds ratio OR 0792 iPi  004 smaller absolute difference qPCR cycle threshold measured 2 week baseline OR 072 iPi  0006 Neither sputum culture sputum Xpert Ultra stool qPCR associated resolution symptom intreatment death Stoolbased TB treatment monitoring correlate sputum culture provides result faster leverage accessible specimen identifies patient TB risk drug resistance persistent 2month culture positivity None quantitative test bacillary burden singularly could predict symptom resolution death",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799783/",
        "source_type": "Global"
    },
    {
        "pmid": "40799590",
        "title": "Minimal immune cell subset differences in a cohort of close contacts of tuberculosis index cases.",
        "abstract": "Understanding perturbation immune response across spectrum TB infection still unclear study followed cohort close contact pulmonary TB patient serial QFT testing 0 3 6 12 months stratified six subgroups QFTincreasing lowhigh QFT converter QFT QFT QFT stable QFT individuals Despite distinct QFT trajectories observed minimal difference immune cell frequencies activation profiles helper subset distribution among QFT subgroups suggesting limited immunological stratification based QFT dynamic alone Ex vivo immune phenotyping including analysis CD4 CD8 NKT cell frequencies memory cell subsets activated cell HLADR⁺CD38⁺ failed distinguish QFT subgroups Antigenspecific CD4 cell response assessed activationinduced marker AIM assay elevated QFT compared QFT individuals finding suggest bloodbased immune profiling may capture subtle immunological transition among QFT converter individual increasing QFT responses contrast individual active TB ATB showed clear immune perturbations ATB patient diagnosis exhibited significantly elevated frequency antigenspecific CD4 cells increased activated cells higher frequency intermediate monocyte NK cell compared QFTQFT contacts Many immune feature declined treatment indicating therapyassociated immune resolution Additionally shift helper subset effector memory population observed course treatment result suggest ex vivo immune profiling robustly distinguish active TB nondiseased states lack resolution differentiate QFT subgroup based QFT dynamic alone could reflect either immunological similarity among close contact regardless QFT status limitation bloodbased phenotyping detecting early subclinical immune shifts study highlight challenge immunologically distinguishing QFTdefined subgroup within close contact using conventional ex vivo profiling approaches",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799590/",
        "source_type": "Global"
    },
    {
        "pmid": "40799565",
        "title": "Sterilizing activity of spectinamide MBX-4888A when replacing linezolid in the Nix- TB regimen in the relapsing BALB/c mouse model of tuberculosis.",
        "abstract": "Spectinamides garnered interest experimental tuberculosis therapeutic owing safety profile efficacy partner agent used conjunction established regimen mice NixTB regimen bedaquiline pretomanid linezolid represents short effective regimen recommended treatment preextensively drugresistant tuberculosis However linezolid administration associated severe adverse event limit use present preclinical data spectinamide MBX4888A replace linezolid NixTB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799565/",
        "source_type": "Global"
    },
    {
        "pmid": "40799379",
        "title": "Overview of antimicrobial resistance mitigation efforts in Benin 2024.",
        "abstract": "Antimicrobial resistance AMR significant global public health threat undermines sustainable development Benin high AMR rate common antibiotics including lastresort treatments exacerbate infection outcome healthcare costs Inappropriate antibiotic use worsens challenge address issues Benin implemented National Multisectoral AMR Action Plan 20192024 study aim assess implementation Benins National AMR Action Plan 20192024 identify critical gap future updates evaluation covered six Benins 12 departments engaging stakeholder human animal environmental health sectors retrospective crosssectional evaluation performed 05 August 2024 30 September 2024 Data collected documentary review standardised questionnaires semistructured interview group discussions executed scoring grid Strengths Weaknesses Opportunities Threats analysis used 224 planned activities 4018 initiated 3125 started 1964 partially executed 536 nearly completed 357 fully implemented Critical gap included lack fully operational multisectoral coordination group limited financial resources inadequate surveillance systems insufficient communication education initiative absence infection prevention control IPC programmes Despite progress regulatory frameworks gap coordination resources surveillance IPC hinder effective AMR control Benin Strengthening governance communication addressing identified gap critical future success evaluation provides evidencebased recommendation update Benins AMR strategy within One Health framework",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799379/",
        "source_type": "Global"
    },
    {
        "pmid": "40799345",
        "title": "Mechanism of the dual action self-potentiating antitubercular drug morphazinamide.",
        "abstract": "Pyrazinamide PZA cornerstone firstline antitubercular drug therapy unique ability kill nongrowing population iMycobacterium tuberculosisi disruption coenzyme CoA metabolism Unlike drugs PZA action conditional requires potentiation hostrelevant environmental stressors low pH nutrient limitation Despite pivotal role tuberculosis therapy durability crucial drug challenged emergent spread drug resistance advance drug discovery efforts characterized activity potent PZA analog morphazinamide MZA Here demonstrate like PZA MZA act part impairment CoA metabolism Unexpectedly find that contrast PZA MZA require potentiation maintains bactericidal activity PZAresistant strain due additional mechanism involving aldehyde release Further find principal mechanism resistance aldehyde component promoter mutation increase expression mycothiol oxidoreductase MscR finding reveal dualaction synergistic mechanism MZA result faster kill rate higher barrier resistance observation provide new insight discovery improved therapeutic approach addressing growing problem drugresistant tuberculosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799345/",
        "source_type": "Global"
    },
    {
        "pmid": "40797354",
        "title": "Adverse effects of linezolid in the treatment of drug-resistant tuberculosis combined with diabetic peripheral neuropathy.",
        "abstract": "aimed observe adverse effect linezolid nerve conduction velocity patient drugresistant tuberculosis combined diabetic peripheral neuropathy Patients hospitalized hospital March 2018 March 2022 divided drugresistant tuberculosis DRTB group type 2 diabetes peripheral neuropathy DPN group type 2 diabetic peripheral neuropathy combined drugresistant tuberculosis DMDRTB group drugresistant TB treatment regimen used linezolid antituberculous drugs Neurophysiological examination performed patient 2 month treatment conduction velocity superficial peroneal nerve peroneal nerve lower limb three group recorded conduction velocity deep peroneal nerve superficial peroneal nerve common peroneal nerve tibial nerve femoral nerve lower limb motor nerve three group compared statistically analyzed 2 month linezolid treatment sensory nerve conduction velocity superficial peroneal nerve sural nerve lower limb DRTB group DMDRTB group significantly decreased difference statistically significant p  005 significant decrease motor nerve conduction velocity deep peroneal nerve superficial peroneal nerve common peroneal nerve tibial nerve femoral nerve lower limb DRTB DMDRTB groups difference statistically significant p  005 Linezolid slow lower limb sensory nerve conduction velocity patient DRTB DMDRTB however effect lower limb motor nerve significant",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797354/",
        "source_type": "Global"
    },
    {
        "pmid": "40797252",
        "title": "Impact of detection rate and preventive treatment of latent tuberculosis infection on the future burden of tuberculosis among students in shanghai: a predictive study using Markov modeling.",
        "abstract": "Students represent key demographic tuberculosis TB control China study utilizes dynamic Markov model forecast epidemiological trend active tuberculosis ATB among student Shanghai 2035 evaluate effectiveness different control strategies Markov model incorporating six distinct state TB transmission utilized simulate disease dynamic within hypothetical cohort 100000 individuals model assessed prevalence latent tuberculosis infection LTBI ATB categorizing case based whether received recommended treatment regimen current measure without additional interventions model projected marginal decline ATB prevalence Specifically ATB prevalence predicted decrease 1480 per 100000 2035 increase tuberculosis preventive treatment TPT coverage 20 50 80 reduction ATB prevalence modest detection rate LTBI fixed 12 combined TPT coverage level 20 50 80 reduction ATB prevalence 1701 3656 5068 respectively Increasing detection rate LTBI 35 alongside TPT coverage 20 50 80 led pronounced decline ATB prevalence 4095 6936 8046 respectively current TB control measures prevalence ATB among student would result marginal decline trajectory 2035 falling substantially short achieving strategic goal ending TB Enhanced strategy simultaneously increase detection rate coverage TPT likely significantly reduce ATB prevalence population online version contains supplementary material available 101186s12889025237509",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797252/",
        "source_type": "Global"
    },
    {
        "pmid": "40797224",
        "title": "Ecological drivers of malaria vector habitat and transmission over 1 year of long-lasting insecticidal net intervention in Côte d'Ivoire.",
        "abstract": "Malaria mosquitoborne parasitic disease cause significant morbidity mortality atrisk populations especially child subSaharan Africa Despite reduction malaria burden owing scaleup effective interventions concern longlasting insecticidal net LLIN effect may sustained owing widespread insecticide resistance differential impact LLIN vector species study aimed test effect different LLIN product environmental factor ecological niche three mosquito vector specie using stateoftheart ecological niche modelling approaches study used data cluster randomized control trial took place Tiébissou Central Côte dIvoire Anopheles mosquito density Plasmodium falciparum vector infection data available across 33 clusters used satellite remote sensing related land cover climate topography population density across study area alongside vector specie occurrence data construct ecological niche model An coluzzi An gambiae ss An funestus ss P falciparuminfected vectors baseline 1year postLLIN intervention compared projected habitat habitat determinant species assessed respective contribution intervention arm environmental factor probability specie occurrence Minimal considerable overall reduction suitable habitat across study area observed three mosquito vector specie less 1 60 considerable overall reduction observed P falciparuminfected vector more 50 detect effect intervention arm probability occurrence vector species found strong significant effect combination land cover climate topography andor population density variable three mosquito vector specie malariainfected vectors result suggest environmental factor may facilitated restricted change probability occurrence vector specie infected vector context vector control interventions study highlight wide ecological difference across malaria vector specie support need consider malaria vector specie composition deploying malaria vector control intervention endemic settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797224/",
        "source_type": "Global"
    },
    {
        "pmid": "40797008",
        "title": "Pyrazolopyridine pyrimidone hybrids as potential DprE1 inhibitors, design, synthesis and biological evaluation as antitubercular agents.",
        "abstract": "Tuberculosis TB remains major global health challenge study present design synthesis evaluation novel pyrazolo34bpyridinepyrimidone derivative targeting Mycobacterium tuberculosis Mtb compound assessed antitubercular activity using Microplate Alamar Blue Assay MABA Mtb H37Rv strain Key derivative 8 14 showed significant activity minimum inhibitory concentration MIC value 312 µgmL 125 µgmL respectively comparable standard drug nontoxic effective concentration antiTB agents Molecular docking study demonstrated strong binding interaction DprE1 MtbDHFR enzymes suggesting inhibition critical proteins computational analyses including density functional theory DFT molecular dynamic simulations confirmed binding stability compound target proteins Overall pyrazolo34bpyridinepyrimidone derivative potential lead development future therapeutic treating drugresistant TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797008/",
        "source_type": "Global"
    },
    {
        "pmid": "40796011",
        "title": "Systematic investigation of baseline nosocomial transmission of tuberculosis in the Kyrgyz Republic, Central Asia.",
        "abstract": "Controlling tuberculosis TB transmission paramount importance combating TB pandemic Although TB hospital considered hotspot transmission systematic longitudinal study examining underlying incidence possible risk factor nosocomial TB transmission lacking objective study detect nosocomial transmission event 20 month period using whole genome sequencing WGS Mycobacterium tuberculosis complex MTBC isolates collected 563 patient pulmonary TB hospitalized Kyrgyz Republic Whole genome sequencing WGS performed 698 Mycobacterium tuberculosis complex MTBC isolates including 563 first isolates recovered participant within four week hospitalization 135 followup isolates treatment control sample collected least four week apart participants roommate recorded whole study period cohort represented 95 TB patient hospitalized study site followup period 53372 hospitalization days Genomebased cluster analysis revealed 173 563 307 first isolates fell 56 cluster 5 SNPs Two nosocomial TB transmission index case roommate proven addition five potential transmission observed patient shared time room hospital index case identified transmitted strain resistant previous one Withincommunity transmission MTBC highly active Kyrgyzstan 137 per 1000 patient year 95CI 16495 observed markedly higher rate nosocomial transmission reported previous WGSbased studies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796011/",
        "source_type": "Global"
    },
    {
        "pmid": "40796001",
        "title": "Model-based evaluation of the interaction between ritonavir-boosted atazanavir and rifampicin in Ugandan adults with HIV.",
        "abstract": "Concomitant treatment tuberculosis TB human immunodeficiency virus HIV complicated drugdrug interaction DDI analysis aimed characterize DDI ritonavirboosted atazanavir ATVr rifampicin plasma peripheral blood mononuclear cell PBMC DERIVE study NCT04121195 recruited Ugandan adult HIV not TB ATVrbased secondline antiretroviral therapy collected intensive plasma PBMC pharmacokinetic sample four visits i standarddose ATVr 300100 mg QD ii ATVr regimen adding rifampicin 600 mg QD iii doubling ATVr BID rifampicin 600 mg QD iv ATVr 300100 mg BID rifampicin increased 1200 mg QD ATVr plasma PBMC concentration analysed population pharmacokinetic modelling NONMEM Twentysix participant 23 female enrolled median age weight 44 year 67 kg respectively twocompartment model effectcompartment effectively described atazanavir concentration plasma PBMC Rifampicin increased atazanavir clearance threefold decreasing bioavailability absorption rate Doubling dosing frequency ATVr largely mitigated interaction rifampicin restoring proportion simulated participant achieving targeted trough atazanavir concentration 0014 mgL 99 Rifampicin affect ratio atazanavir concentration PBMCs plasma Metabolic induction rifampicin account decrease plasma exposure ATVr Doubling ATVr dosing frequency BID effectively mitigated interaction plasma exposure ATVr mirrored PBMCs suggesting drugs plasma concentration provide reliable reflection siteofaction exposures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796001/",
        "source_type": "Global"
    },
    {
        "pmid": "40795373",
        "title": "Single-cell profiling of blood and cerebrospinal fluid in tuberculous meningitis.",
        "abstract": "Tuberculous meningitis TBM severe form tuberculosis fatality rate 20 50 treated individuals Although corticosteroid therapy increase survival HIVnegative people TBM better antimicrobial hostdirected therapy required improve outcome is therefore need better understand local immunopathologic pathways Despite power identifying diseasespecific cellular profiles singlecell RNA sequencing scRNAseq underutilized cerebral sample brain infection employed scRNAseq analyze fresh pretreatment cerebrospinal fluid CSF 4 TBM patients along paired PBMCs 29 cell subtypes present tissues relative abundance varied significantly particular CSF enriched highly inflammatory microglialike macrophages GZMKCD8 effectormemory TEM cells CD56bright NK cells latter 2 subset exhibited reduced cytotoxicity compared bloodenriched counterparts namely cytotoxic GNLYCD8 TEM CD56dim NK cells respectively Across multiple cell types inflammatory signaling pathway increased oxidative phosphorylation decreased CSF compared PBMCs study highlight value scRNAseq exploring CSF immunopathogenesis TBM patient offer resource future study investigating pathophysiology TBM brain infections including potentially targetable cell population linked immunemediated pathology",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795373/",
        "source_type": "Global"
    },
    {
        "pmid": "40795178",
        "title": "Preventing multidrug resistant tuberculosis: the dawn of a new era.",
        "abstract": "Multidrug resistant tuberculosis MDRTB remains global health threat account quarter death due antimicrobial resistance Individuals infected MDRTB risk progressing TB disease Treatment drugresistant TB infection prevent progression disease avert associated morbidity mortality global priority Randomised evidence inform TB preventive treatment guideline lacking Two recently completed trial provide first randomized evidence treatment household contact exposed patient MDRTB daily levofloxacin six month safe efficacious preventing TB Based results World Health Organization updated TB preventive treatment guideline make strong recommendation use levofloxacin six month MDRTB exposed contacts Novel shorter regimen development usher new era treatment MDRTB infection shown safe efficacious",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795178/",
        "source_type": "Global"
    },
    {
        "pmid": "40794705",
        "title": "Deriving Dosages for Levofloxacin Tuberculosis Preventive Treatment for Young People Exposed to Rifampicin-Resistant Tuberculosis.",
        "abstract": "Tuberculosis TB leading single bacterial cause death worldwide 2023 approximately 400 000 people developed multidrug rifampicinresistant TB MDRRRTB complicates treatment TB preventive treatment TPT critical strategy prevent progression TB infection TB disease among risk February 2024 based data 2 randomized controlled trials levofloxacin strongly recommended World Health Organization WHO TPT option people age exposed MDRRRTB uncertainty optimal dosing levofloxacin child adolescent using dispersible solid formulations used pharmacokinetic modeling simulation determine best dosing strategy people aged 19 year formulation levofloxacin previously developed population pharmacokinetic model levofloxacin child 02168 years used applied new harmonized weight bands Simulations conducted using demographic data country highest incidence RR MDRTB Two currently available levofloxacin formulation 100 mg pediatric dispersible tablet 250 mg solid tablets considered dosing regimen weight band developed levofloxacin used TPT people aged 019 year exposed MDRRRTB Doses correspond 833 mgkg 100 mg dispersible tablet 1042 mgkg 250 mg solid tablets dos achieve adequate adult target exposure levels Pragmatic weightband dosing strategy help simplify administration MDRRRTB TPT included guidance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794705/",
        "source_type": "Global"
    },
    {
        "pmid": "40794594",
        "title": "Macrophage Response to Avirulent and Virulent Mycobacterium tuberculosis and Anti-TB Effects of Exosome Treatment.",
        "abstract": "Tuberculosis TB returned leading cause death single infectious agent 2023 Humanmacrophages secreted exosomes play important role combating invading Mycobacterium tuberculosis Mtb However panoramic analysis underlying immune mechanism infected macrophages package mechanism antiTB effect Mtb treated exosomes remain understood conducted comprehensive analysis macrophage infected avirulent virulent Mtb H37Ra  H37Rv exosomes omics phenotypic analyses result showed H37Ra stimulated strong immune response apoptosis macrophage eliminate invading Mtb H37Rv induced severe necrosis immune escape survival Interestingly result suggest macrophage kill Mtb interferongamma IFNγ independent simulative way highlighting central role IFN signaling pathway antiTB response Moreover observed selective transport host Mtb RNAs macrophage exosomes Notably H37Ratreated exosomes displayed higher antiTB effect H37Rvtreated exosomes due enriched proinflammation immune escape related Mtb protein two exosomes respectively Conclusively finding shed new light immune mechanism macrophage response Mtb infection offering new TB treatment strategy promising vaccine candidates",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794594/",
        "source_type": "Global"
    },
    {
        "pmid": "40794122",
        "title": "Mycobacterium tuberculosis curli pili facilitates pathogenicity by modulating central carbon metabolism.",
        "abstract": "Strategies specifically targeting initial hostpathogen interactions hold great promise identification accurate biomarkers tuberculosis TB prevention interventions Mycobacterium tuberculosis Mtb curli pili MTP encoded mtpRv3312A surface adhesin utilised pathogen interact host receptor cells reported suitable target TB diagnostic therapeutic strategies Previous omics study highlighted role MTP potentially play Mtb central carbon metabolism CCM However precise contribution metabolism remains unknown study aimed examine role MTP bioenergetic metabolism Mtb using bedaquiline BDQ inhibit ATP production oxidative phosphorylation OXPHOS extracellular flux analysis Mtb wildtype WT ∆mtp deletion mutant mtpcomplemented strains role MTP regulation CCM assessed using sup13supCsub6submetabolic flux analysis MTP associated increased bacterial respiration decreased carbon catabolism via glycolysis response inhibition ATP synthase BDQ dependence Mtb Δmtp OXPHOS energy production demonstrated greater WT mtpcomplemented strains addition metabolic flux profile revealed Δmtp mutant CCM dysregulated decreasing flux glycolysis tricarboxylic acid cycle glyoxylate dicarboxylate metabolism pentose phosphate pathway comparison WT novel finding show MTP associated regulation bioenergetics metabolism pathway substantiate MTP potential biomarker TB diagnosticstherapeutics novel target vaccinedrug development",
        "mesh_terms": [
            "Mycobacterium tuberculosis",
            "Carbon",
            "Fimbriae, Bacterial",
            "Oxidative Phosphorylation",
            "Diarylquinolines",
            "Energy Metabolism",
            "Bacterial Proteins",
            "Glycolysis",
            "Adenosine Triphosphate",
            "Tuberculosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794122/",
        "source_type": "Global"
    },
    {
        "pmid": "40793863",
        "title": "Genetic determinants of <i>Mycobacterium tuberculosis</i> adaptation and drug efficacy during stationary phase growth.",
        "abstract": "adaptation iMycobacterium tuberculosisi Mtb slowly growing nongrowing state growthlimited condition play crucial role drug tolerance Although mechanism Mtb adaptation growthlimited condition extensively studied remains unclear extent cellular process necessary sustain nongrowing state affect drug efficacy investigate this performed genomewide transposon mutant screen allowed parallel identification gene influence bacterial fitness drug efficacy stationary phase analysis revealed gene encoding SOS response membrane phospholipid biosynthesis proteasomal protein degradation cell wall remodeling critically determine Mtb fitness stationaryphase condition antibiotic exposure Surprisingly found many mutant compromise stationaryphase adaptation result increased fitness antibiotic treatment including recently identified genetic marker associated poor clinical outcomes Furthermore gene involved cell envelope biosynthesis remodeling antibiotic efflux phosphate transport significantly enriched mutant sensitized antibiotics indicating reduced drug entry critical factor limit antibiotic efficacy nonreplicating Mtb demonstrated mutant deficient utilization lipids primary carbon source Mtb infection became tolerant killing rifampicin provided genetic metabolic evidence activity lipid metabolism associated rifampicin efficacy finding provide detailed assessment Mtb gene necessary adaptation stationary phase drug treatment new insight mechanism antibiotic tolerance nongrowing MtbIMPORTANCEIt long known antibiotic efficacy generally proportional bacterial growth rate Yet remains unclear extent growth arrestinduced physiological metabolic change affect drug efficacy Using genomewide transposon mutant screen identified mutant influence iMycobacterium tuberculosisi adaptation drug efficacy stationary phase growth revealed positive negative correlation stationary phase adaptation drug sensitivity identified many mutant compromise stationary phase adaptation result increased fitness antibiotic treatment including identified genetic marker associated poor clinical outcomes result provide new insight mechanism antibiotic tolerance nongrowing Mtb suggest potential target drug development",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793863/",
        "source_type": "Global"
    },
    {
        "pmid": "40792312",
        "title": "Empirical Tuberculosis Treatment in Human Immunodeficiency Virus (HIV)-Associated Fever of Unknown Origin: A Case-Based Rationale.",
        "abstract": "Fever unknown origin FUO people living human immunodeficiency virus PLHIV clinically defined recurrent fever lasting four week outpatient setting three day hospitalization despite thorough diagnostic evaluation evaluation typically includes comprehensive medical history physical examination imaging study such chest radiography extensive range laboratory tests including complete blood counts blood urine cultures metabolic panels Among many possible causes tuberculosis TB stand leading concern given disproportionate burden PLHIV However whether initiate empirical antitubercular therapy HIVpositive patient presenting FUO remains matter clinical debate variability regional TB prevalence resource availability make universal recommendation difficult apply context review available evidence supporting use empirical TB treatment PLHIV FUO aiming guide clinical decisionmaking setting diagnostic certainty elusive",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40792312/",
        "source_type": "Global"
    },
    {
        "pmid": "40791918",
        "title": "Risk factors, molecular analysis and treatment outcomes of amikacin-resistant <i>Mycobacterium avium</i> complex pulmonary disease.",
        "abstract": "Although incidence amikacin AMKresistant iMycobacterium aviumi complex MAC pulmonary disease PD suspected increased limited data available AMKresistant MACPD study evaluated risk factor associated AMK resistance molecular characteristic AMKresistant isolates treatment outcome patient AMKresistant MACPD retrospective casecontrol study included 73 patient severe refractory MACPD history aminoglycoside drug use Patients initial repeat AMK minimum inhibitory concentration MIC ≥64 μg·mLsup1sup classified AMKresistant clarify clinical outcome prognosis observational study conducted 21 patient AMK resistance AMKresistant 52 control AMKsusceptible analysed case AMK resistance previous isolates available AMK MICs elevated compared level prior aminoglycoside administration multivariate analysis risk factors clarithromycin resistance OR 631 95 CI 168237 12 month total duration aminoglycoside use OR 469 95 CI 109202 identified independent risk factor AMK resistance 12 57 21 AMKresistant isolates found mutation irrsi region significant difference AMKresistant AMKsusceptible group term worsening outcomes including introduction home oxygen therapy 38 iversusi 12 p001 3year mortality 33 iversusi 10 p002 Better management strategy patient severe refractory MACPD crucial includes placing strong emphasis preventing AMK resistance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791918/",
        "source_type": "Global"
    },
    {
        "pmid": "40791718",
        "title": "Pharmacokinetics of dexamethasone in tuberculosis meningitis.",
        "abstract": "Dexamethasone recommended adjunctive therapy tuberculosis meningitis TBM Coadministration rifampicin expected reduce dexamethasone exposure TBM effect may pronounced higher rifampicin dos currently evaluated clinical trials pharmacokinetic study nested randomised controlled trial comparing safety highdose rifampicin oral 35 mgkg intravenous 20 mgkg plus linezolid without aspirin v standarddose rifampicin 10 mgkg adult HIVassociated TBM participant received adjunctive oral dexamethasone every 12 hour starting dose 04 mgkgday Dexamethasone concentration measured intensively sampled plasma day 3 study enrolment analysed using nonlinear mixedeffects modelling total 261 dexamethasone concentration 43 participant available model development Eight 18 participant efavirenzbased ART five 11 lopinavirritonavirbased regimen median duration rifampicin therapy time pharmacokinetic sampling 4 day range 07 Dexamethasone pharmacokinetics best described onecompartment disposition model firstorder absorption elimination Typical oral clearance CLF 131 Lh reduced 115 Lh concomitant lopinavirritonavir Highdose rifampicin significant additional effect dexamethasone pharmacokinetic parameter compared standarddose adult HIVassociated TBM high dexamethasone clearance likely related drugdrug interaction rifampicin Highdose rifampicin additional effect dexamethasone exposure pharmacokinetic analysis dexamethasone adult HIVassociated tuberculosis meningitis found high oral clearance 131 Lh likely due drugdrug interaction rifampicin Highdose rifampicin additional effect dexamethasone exposure compared standard dose",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791718/",
        "source_type": "Global"
    },
    {
        "pmid": "40791701",
        "title": "High treatment success among individuals with rifampicin-resistant tuberculosis in Botswana: A retrospective cohort study.",
        "abstract": "study report tuberculosis TB treatment outcome among individual diagnosed rifampicinresistant TB RRTB assesses predictor associated treatment outcomes conducted retrospective study analyse treatment outcome 162 individual RRTB 2016 2023 Treatment outcome proportion estimated using binomial exact method 95 confidence interval CI Predictors treatment outcome assessed using logistic regression models 162 individuals 102 627 male median age 39 interquartile range IQR 2950 individuals 78 481 Greater Gaborone health district 88 543 people living HIV PLWH Among individuals 137 846 95 CI 782 897 successfully treated Males higher odds unfavourable treatment outcome compared female OR  170 95 CI 073 398 Among cured slightly higher proportion observed among PLWH 718 95 CI 621 803 compared people living HIV PNLWH 692 95 CI 587 785 However mortality rate higher PLWH 107 95 CI 55 183 compared PNLWH 66 95 CI 25 138 history TB treatment 103 odds unfavourable treatment outcome 95 CI 040 273 however association statistically significant study show high success rate treatment among individual RR TB significant difference based sex TB treatment history HIV status Higher mortality among PLWH highlight need targeted intervention among highrisk groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791701/",
        "source_type": "Global"
    },
    {
        "pmid": "40791696",
        "title": "Informing People-Centered Target Product Profiles for TB Diagnostics: A Multi-Country Qualitative Study.",
        "abstract": "Timely accurate tuberculosis TB diagnosis remains key challenge highburden settings World Health Organization WHO developed Target Product Profiles TPPs guide diagnostic development largely reflected perspective experts limited input people affected TB qualitative study explored preference experience inform peoplecentered TB diagnostic strategies conducted 75 semistructured interview adult undergoing TB evaluation outpatient clinic India Philippines South Africa Uganda Vietnam Participants purposively sampled ensure diversity sex TB status age treatment Thematic analysis utilized Preferences shaped five interrelated domains perceived diagnostic accuracy sample collection experience timetoresults affordability testing location Diagnostic accuracy consistently prioritized many expressing willingness trade comfort convenience trustworthy results Sputum blood widely trusted despite collection challenges whereas tongue swab urine easier provide perceived less accurate Rapid sameday turnaround valued minimizing emotional distress financial logistical burdens Although testing typically free indirect cost transport lost income remained barriers Hospitalbased testing preferred due trust staff infrastructure though acknowledged appeal communitybased approach reliability privacy ensured People seeking TB care prioritize accuracy trustworthiness even expense comfort convenience preference inform policy updates especially regarding adoption novel sample type testing strategies support uptake equitable access novel diagnostics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791696/",
        "source_type": "Global"
    },
    {
        "pmid": "40791694",
        "title": "Diagnostic accuracy of tongue swab testing in persons with sputum Xpert Ultra Trace results.",
        "abstract": "Molecular amplification tongue swab sample nonsputumbased investigational approach diagnose pulmonary tuberculosis pTB improved manual qPCR method tongue swab recently achieved 90 sensitivity overall diagnosing TB compared sputum microbiologic reference standard Performance characteristic person lowpositive result sputum molecular test unknown Adults South Africa Uganda sputum Xpert MTBRIF Ultra Trace TR result recruited confirmatory evaluation followup underwent symptom evaluation examination chest Xray sputum testing repeat Xpert Ultra two solid liquid mycobacterial cultures two tongue swabs Tongue swab tested using qPCR amplification IS6110 gene single copy detected 1 swab considered TBpositive TR person diagnosed TB baseline reevaluated 1 3 months determined sensitivity specificity tongue swab TB culture alone microbiologic reference standard MRS positive result Xpert Ultra TB culture composite reference standard CRS clinical recommendation TB treatment positive culture baseline 225 enrolled TR participant 115 51 women median age 38 IQR 3047 130 58 people living HIV PWH provided least 1 tongue swab baseline culture reference standard 45 20 positive TB baseline testing 58 26 positive TB MRS 83 37 CRS Sensitivity specificity tongue swab culture 25 95 CI 1340 94 9097 vs MRS 25 95 CI 1438 96 9198 vs CRS 16 926 94 8998 Tongue swab low sensitivity moderately high specificity TB person Trace Xpert Ultra result Tongue swab limited value diagnosing people lowpositive molecular test result uncertain clinical significance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791694/",
        "source_type": "Global"
    },
    {
        "pmid": "40791690",
        "title": "Cumulative TB disease burden following sputum Xpert Ultra 'Trace' results in clinical settings: Results from a multi-site observational clinical study.",
        "abstract": "Highly sensitive molecular tests like Xpert Ultra reshaping TB diagnosisdetecting paucibacillary TB sometimes creating uncertainty detect DNA extremely low quantity may signal disease ambiguity also complicates evaluation novel diagnostic strategies sought monitor adult Trace result Xpert Ultra test estimate risk tuberculosis disease 24 month later conducted multisite clinical observational study South Africa Uganda enrolled ambulatory participant aged 15 year sputum Xpert Ultra Trace result yet initiated TB treatment participant underwent comprehensive clinical evaluation repeated standard sputum TB testing Clinicians deferred treatment recommendation TB status remained uncertain evaluation Untreated participant followed regularly TB diagnosis andor treatment initiation estimated cumulative incidence TB disease defined three reference standards 311 participant Trace result 50 male 57 PLHIV 37 treated TB within last 5 years 24 positive TB within 12 month culture 37 sputum Xpert culture 54 culture clinical diagnosis excluding diagnosed TB baseline patient identified baseline recent TB history abnormal chest xray positive tongue swab higher risk TB diagnosis hazard ratios 26 24 45 respectively followup hazard highest first three month negative baseline evaluation 022 95 CI 019026 per personmonth decreased 001 95 CI 0002 per personmonth 36 612month intervals Approximately half adult adolescent sputum Trace result diagnosed TB disease within twelve months Although TB diagnosis made within 3 months risk remained higher estimated population incidence rate followup period Individuals sputum Trace result receive close clinical monitoring despite initial clinical treatment decision Xpert Ultra Trace result detect low quantity TB DNA creating diagnostic uncertainty complicates clinical decision diagnostics evaluation clinical observational cohort study followed untreated patient Trace result twelve months using survival analysis estimate actual tuberculosis disease risk identify risk factors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791690/",
        "source_type": "Global"
    },
    {
        "pmid": "40791516",
        "title": "Increased proportion of growth-arrested bacilli in acidic pH adaptation promotes <i>Mycobacterium tuberculosis</i> treatment survival.",
        "abstract": "ability iMycobacterium tuberculosisi Mtb adapt growth behavior response host environment promotes survival immune drug stressors However behavior shift singlecell level remains poorly understood Here show Mtb adapts acidic condition increasing proportion bacteria growtharrested state rather uniformly slowing growth rate entire population nongrowing subpopulation exhibit greater tolerance ethambutol Clinical strain displayed higher proportion growtharrested cell neutral acidic conditions suggesting growth arrest serf bethedging strategy infection Though PhoPR twocomponent system contributes regulating nongrowing state show partial regulator nongrowing bacterial subpopulation additional transcriptional regulator involved study demonstrates nongrowing subpopulation Mtb provide fitness benefit active adaptation environmental cue passive consequence stressors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791516/",
        "source_type": "Global"
    },
    {
        "pmid": "40791357",
        "title": "An activator of a two-component system controls cell separation and intrinsic drug resistance in <i>Mycobacterium tuberculosis</i>.",
        "abstract": "Unlike commonly studied rodshaped bacteria mycobacteria grow poles requiring precise coordination division initiation new pole growth mechanism mediate transition largely unknown likely represent rich source drug target treatment mycobacterial infections including tuberculosis Here identify TapA MSMEG3748Rv1697 key regulator transition TapA interacts sensor kinase MtrB septum initiate signaling cascade ultimately result expression essential peptidoglycan hydrolases RipAB amongst others end division Loss TapA disrupts division dysregulates pole formation sensitizes iMycobacterium tuberculosisi mycobacteria several first secondline TB antibiotics establishing TapA potential therapeutic target defining new link cell cycle progression envelope remodeling intrinsic antibiotic resistance mycobacteria",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791357/",
        "source_type": "Global"
    },
    {
        "pmid": "40790778",
        "title": "Analysis of the clinical value and influencing factors of combined detection of tuberculosis-specific cytokines IFN-γ and IL-2 in the diagnosis of active tuberculosis in children and adolescents.",
        "abstract": "study aimed conduct combined detection Mycobacterium tuberculosis MTB infection using tuberculosis TBspecific cytokine interferonγ IFNγ interleukin2 IL2 release assay hospitalized child adolescent TB evaluate clinical value technique diagnosis active TB child adolescents analyze related influencing factors retrospective study conducted collect data suspected pediatric adolescent TB patient hospitalized Chengdu Public Health Clinical Medical Center April 2022 December 2024 combined detection MTB infection using IFNγ IL2 release assay referred dualfactor detection TB infection carried out Microbiological molecular biological test result MTB also obtained total 904 patient diagnosed TB 176 nonTB patient included analysis effectiveness dualfactor TB infection testing related influencing factors combined detection IFNγ andor IL2 demonstrated improved diagnostic performance active tuberculosis ATB sensitivity 9104 specificity 6534 AUC  0782 95 CI 07450818 IFNγ IL2 level showed significant difference MTBpositive MTBnegative subgroup within TB cohort IFNγ 36552 vs 38211 pgml IL2 24156 vs 21312 pgml cytokine markedly elevated TB group compared nonTB control IFNγ 681 pgml IL2 4168 pgml Agerelated variation observed IFNγ P  005 IL2 concentrations Untreated patient exhibited higher median level IFNγ 3979 vs 3060 pgml IL2 2392 vs 1733 pgml treated individuals Among 904 ATB cases 896 81904 falsenegative cytokines Multivariate analysis identified advanced age retreatment TB pleural effusion TST positivity independent risk factor dualnegative result all P  005 pediatric adolescent patients combined detection IFNγ IL2 exhibit high sensitivity specificity diagnosing ATB test convenient stable highly accurate making great significance early diagnosis TB evaluation treatment effects Age positive TST result retreatment TB presence pleural effusion may influence result IFNγ andor IL2",
        "mesh_terms": [
            "Humans",
            "Interleukin-2",
            "Child",
            "Adolescent",
            "Interferon-gamma",
            "Male",
            "Female",
            "Retrospective Studies",
            "Tuberculosis",
            "Child, Preschool",
            "Mycobacterium tuberculosis",
            "Infant",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790778/",
        "source_type": "Global"
    },
    {
        "pmid": "40790736",
        "title": "Risk factors for tuberculosis treatment outcomes: a statistical learning-based exploration using the SINAN database with incomplete observations.",
        "abstract": "Understanding early predictor treatment outcome allows better outcome prediction resource allocation efficient tuberculosis TB management study aimed predict treatment outcome TB patient realworld populationwide health record dataset significant rate incomplete observations addition potential risk factor associated death TB treatment investigated exploited upweighting approach multiple imputation analysis MIA address extreme imbalance response missing data Three algorithm employed TB treatment outcome prediction including logistic regression LOGIT random forest stochastic gradient boosting three model exhibited similar performance predicting treatment outcomes Moreover interpretation LOGIT conducted adjusted odds ratio aORs computed interpretation result compared MIA complete case analysis CCA MIA appropriate method coping missing data addition compared CCA interpretation result MIAderived LOGIT showed statistically significant covariates associated TB treatment outcomes MIA factor TB clinical form involving pulmonary TB extrapulmonary TB aOR  3077 95 confidence interval CI  29943163 retreatment abandonment aOR  2272 95 CI  22092338 absence isoniazid aOR  2072 95 CI  18922269 rifampicin aOR  1968 95 CI  17462218 treatment regimen associated increased odds death conclusion result shed light potential risk factor death TB treatment suggest use simple yet interpretable LOGIT prediction TB treatment outcomes",
        "mesh_terms": [
            "Humans",
            "Risk Factors",
            "Female",
            "Male",
            "Tuberculosis",
            "Middle Aged",
            "Adult",
            "Databases, Factual",
            "Antitubercular Agents",
            "Treatment Outcome",
            "Machine Learning",
            "Outcome Assessment, Health Care",
            "Aged",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790736/",
        "source_type": "Global"
    },
    {
        "pmid": "40790601",
        "title": "Community and Universal Testing for TB among close contacts of microbiologically confirmed pulmonary TB patients in two high TB burden countries: a protocol for a pragmatic cluster-randomised control trial.",
        "abstract": "Tuberculosis TB symptom screening testing using either smear microscopy GeneXpert MTBRIF Ultra Xpert Ultra mainstay diagnosing TB disease case finding Reliance symptombased TB screening result missed TB cases universal TB testing approach might suitable find missing TB case highrisk populations Universal TB testing involves testing TB disease regardless TB symptom risk TB However limited evidence exists support adoption including costeffectiveness study evaluate effectiveness universal TB testing detection TB uptake TB preventive therapy TPT among eligible household community contact high TB setting per country guidelines pragmatic clusterrandomised trial conducted Lesotho Tanzania Drugsensitive TB DSTB index patient aged ≥ 18 years least one contact enrolled microbiologically confirmed TB within ≤ 6 week diagnosis time recruitment study team health facility selected district regions TB index patient contacts randomised either universal TB testing standard TB screening arms Household community contact listed TB index case enumerated invited participate study providing informed consent assent household visits study four substudies including health economics modelling paediatrics microbiology sociobehavioural preparatory crosssectional study conducted delivery pragmatic clusterrandomised trial determine prevalence TB infection TBI TPT eligibility household contact HHCs compare performance QuantiFERONTBGoldPlus QFTPlus QIAreach diagnosing TBI among HHCs TB index patients Clusterrandomised trial community contact tracing conducted phase II trial provide evidence intensive approach hypothesised increase costeffectiveness TB case finding addition provide evidence high TB burden country inherently different cost structure compared intermediate low burden setting previous costeffectiveness analysis undertaken BMC Trial Registry ISRCTN10003903 Registered December 22 2020 Protocol version number date Version 12 dated 15 January 2023 Date recruitment began 1 March 2022 Estimated date recruitment completion 31 July 2025",
        "mesh_terms": [
            "Humans",
            "Contact Tracing",
            "Cost-Benefit Analysis",
            "Mass Screening",
            "Multicenter Studies as Topic",
            "Mycobacterium tuberculosis",
            "Pragmatic Clinical Trials as Topic",
            "Predictive Value of Tests",
            "Tanzania",
            "Tuberculosis, Pulmonary",
            "Randomized Controlled Trials as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790601/",
        "source_type": "Global"
    },
    {
        "pmid": "40790500",
        "title": "Incidental diagnosis of Bardet-Biedl syndrome in a case of abdominal tuberculosis: a case report.",
        "abstract": "BardetBiedl syndrome rare autosomal recessive disease occurring due ciliopathic genetic defect caused mutation gene encoding protein vital BBSome complex complex essential ciliary function cellular signaling multisystem involvement present variety phenotypes 30yearold adult male patient Indian ethnicity presented 2week history ascites dyspnea ascitic fluid analysis confirmed abdominal tuberculosis However patient showed symptom sign syndromic nature patient entirely blind since age 9 years confirmed retinitis pigmentosa complaint progressive weight gain cognitive impairment Examination showed central obesity almondshaped eyes moonshaped face hexadactyly left lower limb Liver functional tests renal function tests lipid profile ultrasonography abdomen abnormal Beales diagnostic criterion confirmed BardetBiedl syndrome patient treated abdominal tuberculosis psychosocial support nutritional counseling provided Effective treatment BardetBiedl syndrome requires genetic counseling personalized care plan includes multidisciplinary team regular monitoring supportive service neuropsychological psychiatric care family support case also increase clinicians awareness presentation BardetBiedl syndrome diagnosis setting without advanced diagnostic modalities",
        "mesh_terms": [
            "Humans",
            "Male",
            "Bardet-Biedl Syndrome",
            "Adult",
            "Incidental Findings",
            "Tuberculosis, Gastrointestinal",
            "Ascites"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790500/",
        "source_type": "Global"
    },
    {
        "pmid": "40790469",
        "title": "Dysbiosis associated with enhanced microbial mobility across the respiratory tract in pulmonary tuberculosis patients.",
        "abstract": "microbiota actively engaged interaction network host among constituent members However comprehensive study examining microbiome profile across various respiratory site pulmonary tuberculosis PTB lacking Here explored diversity microbiome PTB patient across multiple respiratory site investigated potential interaction microbiomes sites total 130 respiratory tract sample collected multiple site 22 patient PTB 14 healthy individuals including oral cavity trachea healthy affected side lungs sample subjected metagenomic sequencing analyze characteristic diversity respiratory microbiome found respiratory tract PTB patient higher microbial diversity seen healthy individual 8182 v 6465 Among them iRothiai iPrevotellai iActinomycesi exhibited higher proportion PTB characteristic high diversity feature oral site prominent PTB especially notable difference iRothia mucilaginosai Additionally iStreptococcusi iNeisseriai iPrevotellai iFusobacteriumi strong interaction specie present various site PTB patients well frequent communication specie migration upper lower respiratory tract diversity translocation microbiota across respiratory tract PTB patient associated increased susceptibility microbiome predominance iRothiai iPrevotellai iActinomycesi may represent progressionassociated microbial signatures warranting mechanistic study pathogenic potential hostmicrobe interaction guide therapeutic targeting online version contains supplementary material available 101186s1286602504206x",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790469/",
        "source_type": "Global"
    },
    {
        "pmid": "40790221",
        "title": "Gut microbiota profile in newly diagnosed pulmonary tuberculosis patients: an exploratory pilot study in southern India.",
        "abstract": "Emerging evidence suggests link pulmonary tuberculosis PTB gut microbiota dysbiosis first study southern Indian population characterized gut microbiota PTB patient using 16 amplicon sequencing analysis revealed significant reduction gut microbial diversity among PTB patients particularly lower alpha diversity Chao1 index p ≤ 00001 healthy control HC depleted antitubercular therapy ATT Beta diversity indicated distinct clustering group p  005 Subgroup analysis showed supplementation probiotic ATT improved microbial richness diversity However broader shift composition observed genus level specific taxon upregulated downregulated PTB patient compared HC Functional analysis showed depletion biosynthesis pathway PTB patients Shortterm probiotic supplementation partial effect microbial recovery fully restore gut microbial diversity finding highlight persistent dysbiosis PTB patients even ATT Largescale study needed evaluate role microbiometargeted therapy address dysbiosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790221/",
        "source_type": "Global"
    },
    {
        "pmid": "40790202",
        "title": "Nano delivery of MiR-146a and its effect study on genes involved in apoptosis and autophagy pathways in lung cancer and tuberculosis.",
        "abstract": "Tuberculosis TB lung cancer LC among leading cause death worldwide present serious challenge diagnosis treatment Therefore developing new strategy treatment crucial MicroRNAs miRNAs biological molecule play critical role regulating essential processes apoptosis autophagy TB LC targeting specific genes Recently carbon nanotube functionalized Polyethyleneimine CNTPEI deliver miRNAs target cell investigated enhance therapeutic effects study miR146a transfected LC A549 macrophage infected TB THP1 healthy lung cell MRC5 using CNTPEI Then expression miR146a target gene TNF receptorassociated factor6 TRAF6 gene involved apoptosis autophagy pathway including BCL2 IL6 tumor necrosis factoralpha TNFα measured using RealTime PCR Finally effect overexpression miR146a gene investigated three cell lines result showed successful transfection miR146a using CNTPEI nano delivery system LC TB cell models Then increased expression miR146 increased apoptosis autophagy targeting TRAF6 gene affecting gene BCL2 IL6 TNFα NFkB signaling pathway finding suggest important role miR146a TB LC regulates inflammatory response treat diseases However study needed using CNTPEI vivo well balance local antiinflammatory noninflammatory factors",
        "mesh_terms": [
            "MicroRNAs",
            "Humans",
            "Autophagy",
            "Apoptosis",
            "Lung Neoplasms",
            "Nanotubes, Carbon",
            "Tuberculosis",
            "Polyethyleneimine",
            "TNF Receptor-Associated Factor 6",
            "A549 Cells",
            "Transfection",
            "Intracellular Signaling Peptides and Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790202/",
        "source_type": "Global"
    },
    {
        "pmid": "40789978",
        "title": "Exploratory investigation of urinary alkanes and other volatile organic compounds in paediatric patients with tuberculous meningitis.",
        "abstract": "Tuberculous meningitis TBM disease caused Mycobacterium tuberculosis M tb infection brain Alkanes volatile organic compound VOCs biologically important metabolite used infectious mycobacteria specie growth survival strategies study investigated altered alkane VOCs urine paediatric case TBM used untargeted gas chromatography coupled timeofflight mass spectrometry GCTOFMS analyse compare volatile underivatised compound present urine 27 confirmed case paediatric TBM treatment period six months well control group n  13 Four elevated alkane pentadecane 57dimethylundecane 47dimethylundecane 26dimethylundecane three alkene decreased 25dimethyl2hexene 44dimethyl1pentene increased 3methoxy1pentene three VOCs biological interest decreased 2butenoic acid methyl ester 3heptanone increased 2pyrrolidinone identified statistically significant volatile compound remained perturbed TBM treatment study discovered new systemic metabolic information M tb host role alkane VOCs potential persistence M tb demonstrate value targeting alkane VOCs future metabolomics study M tb",
        "mesh_terms": [
            "Humans",
            "Alkanes",
            "Volatile Organic Compounds",
            "Child",
            "Female",
            "Male",
            "Gas Chromatography-Mass Spectrometry",
            "Tuberculosis, Meningeal",
            "Child, Preschool",
            "Adolescent",
            "Mycobacterium tuberculosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789978/",
        "source_type": "Global"
    },
    {
        "pmid": "40789248",
        "title": "Integrating WGCNA and machine learning to distinguish active pulmonary tuberculosis from latent tuberculosis infection based on neutrophil extracellular trap-related genes.",
        "abstract": "Pulmonary tuberculosis PTB remains major global public health challenge diagnostic delay key factor contributing high morbidity mortality Growing evidence suggests neutrophil extracellular trap NETs closely associated PTB pathogenesis study focus elucidating role NETs PTB identifying critical diagnostic method potential biomarkers Weighted gene coexpression network analysis WGCNA employed identify three module strongly correlated NETs Differentially expressed gene DEGs GSE39939 dataset intersected module gene obtain NETrelated DEGs Four machine learning algorithm LASSO random forest RFE Boruta applied select feature gene develop PTB diagnostic model Models performance evaluated using support vector machine SVMbased receiver operating characteristic ROC precisionrecall PR curves validation GSE39940 dataset optimal algorithm selected refine feature gene construct miRNAgene regulatory network ROC PR curve analysis revealed RFE Boruta algorithm exhibited superior diagnostic efficacy distinguishing active PTB latent TB infection LTBI analysis identified five overlapping highranking feature gene GPR84 SIGLEC10 CCR2 TMEM167A GYG1 RFE Boruta algorithms hsamiR1264 hsamiR664a3p hsamiR548e5p hsamiR4775 hsamiR5056 predicted potentially target genes RFE algorithm achieves high diagnostic accuracy PTB identifies five potential biomarkers GPR84 SIGLEC10 CCR2 TMEM167A GYG1 finding may provide valuable tool PTB diagnosis treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789248/",
        "source_type": "Global"
    },
    {
        "pmid": "40788892",
        "title": "Barriers to leprosy elimination in Bolivia: Exploring perspectives and experiences of medical professionals and leprosy patients-A phenomenological study.",
        "abstract": "Leprosy elimination recently reentered global health sphere World Health Organisations WHO Towards zero leprosy strategy 20212030 Previously elimination defined prevalence less 1 case per 10000 achieved global scale 2000 leading large withdrawal resource leprosy control neglect global national scales Despite this leprosy continued spread affect hundred thousand people annually study explores barrier leprosy elimination Bolivia using phenomenological approach discover perception experience leprosy patient medical professional regarding leprosy Bolivia also explores role active case finding ACF leprosy elimination Bolivia Indepth semistructured interview conducted Spanish mainly Jorochito Dermatological Hospital national referral centre leprosy Bolivia Barriers leprosy elimination Bolivia present provider patient governmental societal community levels include poor health financing untrained workforce poor treatment adherence centralised organisation leprosy diagnosis treatment health illiteracy barrier leprosy elimination Bolivia complex interconnected embedded Bolivian society Leprosy elimination must given priority global national scale increase funding importance continue ACF activities promote national solution sustainable leprosy control",
        "mesh_terms": [
            "Humans",
            "Bolivia",
            "Leprosy",
            "Male",
            "Female",
            "Disease Eradication",
            "Health Personnel",
            "Adult",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788892/",
        "source_type": "Global"
    },
    {
        "pmid": "40788398",
        "title": "Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis.",
        "abstract": "persistent rise multidrugresistant MDR bacteria represents significant public health challenge necessitating exploration alternative therapeutic options slow pace approval new antituberculosis TB medication underscore urgent need identify potential alternative agents Gallic acid GA possesses numerous biological properties including antibacterial antiseptic effects study standard MDR strain M tuberculosis utilized assess antibacterial efficacy GA related mechanisms GA achieved minimum inhibitory minimum bactericidal concentration comparable examined antibiotic significantly lower cytotoxicity THLE3 cell line pvalue  005 Furthermore GA displayed bactericidal properties enhanced effectiveness moxifloxacin levofloxacin MDR M tuberculosis modulated expression efflux pump genes specifically Rv1410c Rv1258c pvalue  0001 result contribute deeper understanding GAs antibacterial potential suggest novel alternative approach managing MDR bacterial infections",
        "mesh_terms": [
            "Gallic Acid",
            "Mycobacterium tuberculosis",
            "Microbial Sensitivity Tests",
            "Antitubercular Agents",
            "Drug Resistance, Multiple, Bacterial",
            "Humans",
            "Tuberculosis, Multidrug-Resistant",
            "Cell Line",
            "Levofloxacin",
            "Moxifloxacin",
            "Bacterial Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788398/",
        "source_type": "Global"
    },
    {
        "pmid": "40788340",
        "title": "Endoplasmic reticulum: the target of chlamydial manipulation.",
        "abstract": "Chlamydia obligate intracellular pathogen cause significant human disease trachoma sexually transmitted infections respiratory illnesses atherosclerosis Understanding unique survival strategy within host cell crucial developing effective treatments endoplasmic reticulum ER key target intracellular pathogen due role fundamental cellular functions Chlamydia form membrane contact site MCSs ER physical connection allows Chlamydia obtain sphingomyelin regulate calcium ion concentration via ER thereby promoting inclusion formation facilitating inclusion extrusion Additionally chlamydial infection trigger ER stress downstream unfolded protein response UPR leading autophagy expression inflammatory factors oxidative stress OS dual role survival pathogenesis Chlamydia focusing interaction Chlamydia ER highlight mechanism underlying lipid acquisition calcium signaling subversion UPR insight advance understanding Chlamydias pathogenesis also reveal potential therapeutic target treat chlamydial infections",
        "mesh_terms": [
            "Endoplasmic Reticulum",
            "Humans",
            "Chlamydia Infections",
            "Chlamydia",
            "Unfolded Protein Response",
            "Endoplasmic Reticulum Stress",
            "Animals",
            "Host-Pathogen Interactions",
            "Oxidative Stress",
            "Autophagy",
            "Calcium Signaling"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788340/",
        "source_type": "Global"
    },
    {
        "pmid": "40788226",
        "title": "Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data.",
        "abstract": "phase 3 ALLIANCE study bictegraviremtricitabinetenofovir alafenamide BFTAF dolutegravir plus emtricitabinetenofovir disoproxil fumarate DTG  FTDF achieved high rate HIV1 RNA suppression week 96 adult HIV1 hepatitis B virus initiating treatment NCT03547908 study quantify preexisting HIV1 resistance evaluate effect HIV1 virologic suppression describe postbaseline HIV1 resistance week 96 Preexisting HIV1 resistance assessed historical andor screening genotyping HIV1 RNA suppression 50 copy cmL week 96 assessed preexisting resistance category Postbaseline resistance assessed participant HIV1 RNA ≥200 cmL week 96 Primary nucleosidenucleotide reverse transcriptase inhibitor nonnucleoside reverse transcriptase inhibitor protease inhibitor resistance substitution present baseline 4 17 19 79 5 21 241 participants respectively Virologic suppression rate high irrespective preexisting primary resistance substitutions including M184I Six participant 3 per group confirmed HIV1 RNA ≥200 cmL resuppress 50 cmL study drugs none 5 postbaseline resistance data treatmentemergent primary resistance substitutions One participant DTG  FTDF multiple virologic failure documented nonadherence pill count treatmentemergent K70E M184VI subsequently resuppressed people HIV1 hepatitis B virus treated firstline BFTAF DTG  FTDF preexisting HIV1 resistance uncommon affect virologic suppression treatmentemergent HIV1 resistance occurred BFTAF supporting high barrier resistance regimen",
        "mesh_terms": [
            "Adult",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Adenine",
            "Alanine",
            "Anti-HIV Agents",
            "Dibenzocycloheptenes",
            "Drug Combinations",
            "Drug Resistance, Viral",
            "Drug Therapy, Combination",
            "Emtricitabine",
            "Hepatitis B",
            "Heterocyclic Compounds, 3-Ring",
            "Heterocyclic Compounds, 4 or More Rings",
            "HIV Infections",
            "HIV-1",
            "Oxazines",
            "Piperazines",
            "Pyridones",
            "Tenofovir",
            "Viral Load",
            "Amides"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788226/",
        "source_type": "Global"
    },
    {
        "pmid": "40787981",
        "title": "Characterization of PPE19 as a novel mediator of <i>Mycobacterium tuberculosis</i>-macrophage interactions.",
        "abstract": "iMycobacterium tuberculosisi Mtb highly adapted human pathogen capable manipulating host immunity study demonstrates PPE19 member PEPPE protein family facilitates Mtb adhesion to invasion murine macrophages PPE19coated microspheres showed enhanced uptake macrophage compared control beads Mtb overexpressing ippe19i Rv1361c phagocytosed significantly greater rate WT Mtb ippe19i identified pH responsive display reduced expression following macrophage entry CRISPR interferencemediated knockdown two highly related PPE proteins ippe18i Rv1196 ippe60i Rv3478 revealed additive reduction Mtbs ability invade host macrophages indicating potential functional relationship Furthermore absence iin vivoi phenotype following murine infection ippe19i knockout strain suggests functional redundancy within PPE protein family Finally PE13 identified binding partner PPE19 characterizing another relationship presumed important successful PPE secretion finding reveal PPE19 secreted effector protein used Mtb modulate important early interaction innate immune system enhancing entry host macrophagesIMPORTANCETuberculosis remains leading infectious disease killer worldwide approximately onequarter global population infected iMycobacterium tuberculosisi Mtb Understanding pathogen initially establishes infection crucial developing effective vaccine treatments study identifies PPE19 previously uncharacterized bacterial protein key factor help Mtb invade colonize human immune cell called macrophage earliest stage infection research show PPE19 act like molecular key facilitates bacterial entry host cell downregulated bacteria safely inside Importantly PPE19 belongs family similar protein compensate other explaining targeting individual member may sufficient treatment finding provide new insight tuberculosis pathogenesis suggest early infection factor like PPE19 could serve target nextgeneration vaccine designed prevent initial infection rather disease progression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787981/",
        "source_type": "Global"
    },
    {
        "pmid": "40787500",
        "title": "Pakistan's path forward in DR-TB management: insights from global implementation of BPaL/BPaLM regimen.",
        "abstract": "Drugresistant tuberculosis DRTB serious public health threat Pakistan one impacted nations long treatment duration traditional regimen put great burden healthcare systems especially resourceconstrained environments Accordingly World Health Organization launched Bedaquiline Pretomanid Linezolid BPaLBedaquiline Pretomanid Linezolid Moxifloxacin BPaLM regimen  6month alloral therapy consisting BPaLM stated success rate high 90 regimen present exciting alternative traditional treatments Yet integration current treatment program hindered policy lags poor diagnostic infrastructure difficulty maintaining patient compliance brief communication explores promise BPaLBPaLM enhance DRTB cure rate pinpointing major hurdle use Pakistan Enhancing diagnostic capacity upgrading healthcare infrastructure accelerating policy adjustment crucial step toward maximizing DRTB management highburden countries",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787500/",
        "source_type": "Global"
    },
    {
        "pmid": "40787485",
        "title": "Isolated renal tuberculosis presenting as staghorn calculi and hydronephrosis - a case report and literature review.",
        "abstract": "TB major health concern caused Mycobacterium tuberculosis primarily affect lung also manifest extrapulmonary TB EPTB Genitourinary tuberculosis GUTB rank third among extrapulmonary TB cases following lymphatic pleural involvement 45yearold female Amahra Ethiopia presented longstanding flank pain constitutional symptoms lower urinary tract symptoms significant comorbidities Physical examination unremarkable except left costovertebral angle tenderness Abdominal imaging revealed normal renal parenchyma left hydronephrosis staghorn calculus unilateral nephrectomy performed surprisingly pathological analysis suggested renal tuberculosis patient subsequently treated 6month course antituberculosis therapy Isolated renal tuberculosis RTB rare often difficulttodiagnose form TB due nonspecific symptoms Presentations range asymptomatic severe including complication like staghorn calculus masses Rena TB typically associated certain risk factors occur even absence case patient resided high TB burden area Mycobacterium tuberculosis usually reach kidney via hematogenous spread lungs though direct spread also possible isolated renal involvement rare Diagnosis isolated renal tuberculosis challenging often requiring histopathology nephrectomy biopsy urine culture may unrevealing Imaging finding vary disease stage CT best calcification CT IVP offering broader sensitivity Treatment involves antituberculosis medication guided national guidelines medication often sufficient advanced case may require surgical intervention like nephrectomy choice dependent factor like disease extent renal function Isolated renal tuberculosis RTB rare difficult diagnose due varied symptom Early detection treatment antiTB drug key preventing irreversible kidney damage nephrectomy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787485/",
        "source_type": "Global"
    },
    {
        "pmid": "40787208",
        "title": "Pre-treatment Circulating Tumor Cell Associated White Blood Cell Clusters Independently Predict Poor Survival in Patients with Extensive-disease Small Cell Lung Cancer.",
        "abstract": "Patients extensive disease EDsmall cell lung cancer SCLC commonly suffer inferior prognosis limited disease LDSCLC study aim investigate heterogeneity prognostic significance various aneuploid circulating tumor cell CTCs subtypes CTCassociated white blood cell CTCWBC cluster patient LDand EDSCLC respectively prospective noninterventional singlecenter study included 48 patient LDSCLC 47 patient EDSCLC total 95 SCLC patient prospectively enrolled serial blood sample obtained chemotherapy administration tsub0sub 2 cycle chemotherapy tsub1sub Comprehensive situ codetection CTCs CTCWBC cluster performed enrolled patients analysis revealed significant difference CTCs quantity LDSCLC EDSCLC patient iPi  610 However significant morphologic heterogeneity CTCs including cell size chromosome 8 Chr8 ploidy CTCs observed 2 group iPi  001 iPi  001 Patients posttherapeutic small cell CTCs ⩾ 26 ml triploid CTCs ⩾ 26 ml exhibited reduced overall survival OS compared small cell CTCs  26 ml triploid CTCs  26 ml EDSCLC iPi  011 iPi  018 Additionally positive detection posttherapeutic tetraploid CTCs associated inferior survival LDand EDSCLC iPi  041 iPi  049 presence CTCWBC cluster baseline treatment significantly correlated inferior OS EDSCLC iPi  016 iPi  028 LDSCLC iPi  355 iPi  621 Multivariate analysis identified brain metastasis pretreatment CTCWBC cluster independent prognostic factor OS EDSCLC patient iPi  004 iPi  013 Ideal biomarkers specific survival prediction patient different disease stages Pretreatment CTCWBC cluster independently predict inferior OS EDSCLC LDSCLC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787208/",
        "source_type": "Global"
    },
    {
        "pmid": "40786765",
        "title": "Disseminated Skeletal Cryptococcosis: A Case Report.",
        "abstract": "Cryptococcus rare cause osteomyelitis especially immunocompromised individuals case report discusses rare case disseminated cryptococcosis multiple bone lesion patient isolated CD4 lymphocytopenia 31yearold apparently normal Indian male presented pain swelling right proximal femur 8 month without history trauma also reported similar swelling chest wall allergic respiratory symptom 8 years Laboratory analysis revealed mild elevation inflammatory markers Magnetic resonance imaging pelvis revealed osteolytic lesion right proximal femur pubic bone soft tissue collections computed tomography scan chest showed osteolytic lesion right 9th rib overlying soft tissue collection subpleural cavitary nodule left lower lobe posterior basal segment Although initially treated case clinically diagnosed tuberculosis patient get relief antitubercular therapy Fine needle aspiration cytology fungal culture identified Cryptococcus neoformans lesion blood culture patient responded well antifungal treatment currently symptom free Cryptococcosis considered rare differential diagnosis patient presenting bone pain multiple lytic lesions Definitive diagnosis requires fungal culture affected areas Early treatment antifungal important preventing complication death",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786765/",
        "source_type": "Global"
    },
    {
        "pmid": "40786676",
        "title": "Surgical Management of Cervical Canal Stenosis with Clinical Tuberculosis Using Foley's Catheter Stent: A Case Report.",
        "abstract": "Uterine cervical canal stenosis lead significant complications particularly context active clinical tuberculosis case study discusses 25yearold woman undiagnosed clinical tuberculosis presented amenorrhea persistent abdominal pain evaluation revealed uterine cervical canal stenosis frozen pelvis Surgical intervention necessary confirming diagnosis clinical assessment laparotomy hysterotomy performed Foleys catheter used create patent uterocervical channel innovative approach successfully alleviated abdominal pain restored menstrual function patients recovery smooth symptom improved markedly case underscore importance recognizing cervical stenosis potential consequence tuberculosis demonstrates effectiveness surgical treatment managing complex case without resorting hysterectomy bilateral salpingooophorectomy thereby preserving reproductive potential woman childbearing age",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786676/",
        "source_type": "Global"
    },
    {
        "pmid": "40786644",
        "title": "Cutaneous leishmaniasis in a renal transplant patient: Diagnostic challenges in a non-endemic setting.",
        "abstract": "Leishmanial infections though uncommon Southeast Central Asia remain clinically significant due potential cause substantial morbidity mortality case report present young Nepalese male four year postrenal transplant chronic allograft dysfunction secondary noncompliance presented right chest skin lesion fever Initially suspected cutaneous tuberculosis malignancy investigations including skin biopsy revealed cutaneous leishmaniasis patient responded well treatment liposomal amphotericin B highlighting importance considering leishmaniasis differential diagnoses especially immunocompromised individual from travelling to endemic regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786644/",
        "source_type": "Global"
    },
    {
        "pmid": "40786601",
        "title": "Multimorbidity in tuberculosis (TB) and its impact on patient care (MITICare): a cross-sectional study nested within a prospective cohort study protocol.",
        "abstract": "Multimorbidity defined two coexisting longterm health conditions increasing low middleincome countries overlapping ongoing high tuberculosis TB incidence known high prevalence multimorbidity patient TB South Africa understanding common TBmultimorbidity African countries effect trajectory TB care limited crosssectional study nested within prospective cohort codesigned Infectious Diseases Institute Uganda University St Andrews United Kingdom aim describe burden evaluate consequence multimorbidity among patient TB disease Kampala Uganda primary objective describe prevalence multimorbidity start treatment TB secondary objective determine effect multimorbidity clinical characteristic start treatment progress TB care end TB treatment outcomes 254 adult commencing treatment TB shall recruited Multimorbidity shall assessed using structured questionnaires simple examination blood analysis Th clinical characteristic TB shall determined using health quality life score and patient pulmonary TB degree chest Xray abnormality sputum bacillary burden Patients shall followedup two six month response treatment determined analysis prevalence multimorbidity baseline shall reported using proportion 95 confidence interval secondary objectives regression model adjusting confounders identified directed acyclic graph used study developed close collaboration core patient public involvement group also actively involved dissemination study results Ugandan St Andrews University ethical approval prospectively granted IDIREC202382 MD17720 HS3888ES",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786601/",
        "source_type": "Global"
    },
    {
        "pmid": "40786295",
        "title": "Diagnosis and Treatment of Plasmablastic Lymphoma in an Immunocompetent Patient: A Report of a Rare Case.",
        "abstract": "Plasmablastic lymphoma PBL rare aggressive subtype diffuse large Bcell lymphoma DLBCL often associated immunodeficiency state HIV infection However PBL also occur HIVnegative individuals exhibit diverse anatomical involvement poorer prognosis case present 50yearold HIV negative male patient progressive lower limb weakness numbness due thoracic paravertebral lesion extending T1 T6 causing compressive myelopathy Imaging raised concern malignancy histopathology confirmed PBL positivity IHC CD38 CD138 Cyclin D1 Given aggressive nature early intervention critical patient underwent surgical decompression via T2T6 laminectomy followed chemotherapy EPOCH regimen etoposide prednisone vincristine cyclophosphamide doxorubicin two cycles significant symptomatic improvement observed HIVnegative PBL associated poor prognosis high relapse rates necessitating aggressive treatment close monitoring case highlight challenge diagnosing managing HIVnegative PBL emphasizing importance multimodal treatment strategies including surgical intervention intensive chemotherapy followup",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786295/",
        "source_type": "Global"
    },
    {
        "pmid": "40786068",
        "title": "Fabrication and optimization of freeze-dried isoniazid-loaded poly-<i>ε</i>-caprolactone nanoparticles.",
        "abstract": "Microfluidic nanoprecipitation followed freezedrying would yield uniformly sized stable nanoparticles preserving physicochemical property without compromising therapeutic performance isoniazid INHloaded polyiεicaprolactone PCL nanoparticles could developed using microfluidic technique management tuberculosis INHloaded nanoparticles fabricated via microreactorassisted nanoprecipitation method optimization using design experiment factorial design approach resulting INHPCL nanoformulation characterized particle size polydispersity index PDI zeta potential surface charge Fouriertransform infrared spectroscopy differential scanning calorimetry Xray diffraction analysis field emission scanning electron microscope optimized nanoparticles exhibited average particle size 2484 ± 5372 nm high encapsulation efficiency 8226 ± 436  Thermal spectroscopic analysis confirmed absence drugpolymer interactions ensuring formulation integrity stability study accelerated condition demonstrated negligible change particle size PDI zeta potential period 6 months indicating robust colloidal stability scanning electron microscopy study revealed rodshaped nanoparticles smooth surfaces Lyophilization freezedrying enhanced longterm stability yielding readily redispersible powder reconstitution index 1066 Following diffusioncontrolled kinetics vitro drug release study phosphate buffer saline pH 74 showed sustained drug release 9245  cumulative release 48 h result confirm INHloaded PCL nanoformulation combine excellent stability high drugloading capacity sustained release key attribute effective tuberculosis therapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786068/",
        "source_type": "Global"
    },
    {
        "pmid": "40785800",
        "title": "Efficacy of Belimumab for Active Lupus Nephritis in a Young Asian Man with Latent Pulmonary Tuberculosis: A Case Report.",
        "abstract": "Managing active lupus nephritis LN presence latent tuberculosis TB present significant treatment challenge Traditional treatment glucocorticoid combined mycophenolic acid carry high risk triggering pulmonary TB infection LN patients report discus novel approach using belimumab combination rapidly tapering corticosteroid treat patient active class IV V LN latent TB 24yearold Chinese male diagnosed active class IV V LN latent TB underwent induction therapy combination belimumab rapidly tapering methylprednisolone mycophenolate mofetil 18 month belimumab therapy patients blood albumin level kidney function normalized 24h urinary protein level stabilizing 500 mg 725 mg Notably recurrence TB case demonstrates combination belimumab rapid corticosteroid tapering effectively reduced duration highdose glucocorticoid therapy highlighting efficacy safety belimumab managing LN latent TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785800/",
        "source_type": "Global"
    },
    {
        "pmid": "40785622",
        "title": "Risk Factors and Outcomes of Catheter-Associated Urinary Tract Infections in the Intensive Care Unit of a Tertiary University Hospital: A Prospective Study.",
        "abstract": "Catheterassociated urinary tract infection CAUTIs common among patient admitted intensive care unit ICU ICUrelated CAUTI associated longer hospital stays greater financial burden greater antibiotic use impact mortality study aimed address incidence risk factors causative pathogen outcome CAUTI among patient admitted ICU tertiary University Hospital prospective study adult patient admitted ICU University Hospital indwelling urinary catheter IUCs admission included Based occurrence CAUTI study cohort divided two groups CAUTI without CAUTI incidence risk factors causative pathogen outcome patient CAUTI addressed One hundred forty patient enrolled mean age 4384 ± 1386 years 69140 493 male incidence CAUTI 435 CAUTI significantly related older age female sex smoking postsurgery diabetes mellitus DM obstructive uropathy immobility faecal incontinence duration urinary catheterisation Cox regression analysis revealed significant risk factor CAUTI duration urinary catheterisation DM postsurgery hazard ratio 714 95 confidence interval CI 3781463 p  0001 625 95 CI 3131147 p  0001 234 95 CI 123445 p  0010 respectively current study show incidence CAUTI among ICU patient high Numerous risk factor CAUTI identified included older age female sex longer duration catheterisation smoking postsurgery DM obstructive uropathy immobility significant risk factor CAUTI duration urinary catheterisation DM postsurgery Special precaution needed prevent CAUTI among ICU patient risk factors result study implication daily ICU practice important identify highrisk patient consider targeted preventive measures Ongoing education healthcare worker CAUTI prevention management taken account",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Prospective Studies",
            "Risk Factors",
            "Urinary Tract Infections",
            "Catheter-Related Infections",
            "Adult",
            "Intensive Care Units",
            "Hospitals, University",
            "Middle Aged",
            "Incidence",
            "Tertiary Care Centers",
            "Urinary Catheterization",
            "Length of Stay"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785622/",
        "source_type": "Global"
    },
    {
        "pmid": "40785321",
        "title": "Adverse drug reactions, particularly liver disorders, drive interruptions in anti-tuberculosis treatment: A retrospective cohort study.",
        "abstract": "Adverse drug reaction ADRs key driver missed dos antituberculosis TB therapy aimed determine relative burden ADRdriven missed doses missed dose pattern associated ADRs association specific ADRs missed doses retrospective cohort study adult ≥18 years began standard 6month drugsensitive antiTB regimen outpatient facility Riga Latvia May 2015September 2022 missed least one dose treatment included Data collected medical record observed therapy records Missed dos subdivided early discontinuation sporadically missed Descriptive analysis lasagne plot used Across 174 patients 54 310 CI 242379 missed dos due ADRs 31 320 doses 4217 135 CI 131139 missed 209 8804217 CI 196221 due ADRs Eighteen 103 174 patient discontinued treatment early two 111 due ADRs Doses missed due ADRs caused longer yet less frequent period sporadic missed doses 564 479849 sporadic missed dos 1 day length vs 91 777 ADRrelated ones Hepatobiliary disorder leading ADR group causing missed doses Hepatobiliary ADRs caused long median duration missed dos median 150 CI 130220 study underscore importance ADRs cause missed dos treatment particularly hepatobiliary disorders Regimens less prone ADRs strong healthcare system support structure patient ADRs required minimize missed doses reducing unfavourable outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785321/",
        "source_type": "Global"
    },
    {
        "pmid": "40784749",
        "title": "Brain abscess with concurrent infection: tuberculosis and aspergillosis.",
        "abstract": "Brain abscess rarely caused coinfection different pathogens middleaged immunocompetent woman developed rightsided focal motor seizure Todds palsy Brain imaging identified frontal ringenhancing lesion started antitubercular therapy corticosteroids However tapering corticosteroids developed rightsided hemiparesis increased lesion size Excision biopsy identified coinfection iMycobacterium tuberculosisi iAspergillus sppi recovered well antitubercular antifungal agents Coinfections multiple pathogen pose diagnostic challenge due overlapping nonspecific clinical radiological features case underscore importance tissue diagnosis enable appropriate therapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784749/",
        "source_type": "Global"
    },
    {
        "pmid": "40784588",
        "title": "Impact of age-stratified latent tuberculosis treatment on disease burden of active tuberculosis: A mathematical modeling study in an aging country with a high disease burden.",
        "abstract": "Republic Korea highest tuberculosis TB incidence among OECD countries older adult elevated risk reactivation However latent TB infection LTBI control strategy often exclude individual 65 due potential side effects hepatotoxicity Identifying optimal age group intervention critical developed agestructured dynamic transmission model simulate TB LTBI progression Korea model calibrated using TB case data 20112018 Korea Disease Control Prevention Agency Health Insurance Review Assessment Service projected TB case averted 30 year evaluating LTBI treatment strategy varying coverage success rate across age groups Targeting LTBI treatment adult aged 3564 resulted greatest reduction TB incidence fourfold increase LTBI treatment rate group averted 32814 casescompared 11564 5689 case 1934 ≥65 age groups respectively Increasing probability treatment success smaller similar effect Prioritizing LTBI treatment 3564 age group may substantially reduce TB burden support agestratified strategy national TB control",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784588/",
        "source_type": "Global"
    },
    {
        "pmid": "40783679",
        "title": "Remimazolam is more suitable for general anesthesia bronchoscopy in tuberculosis patients treated with isoniazid: a retrospective cohort analysis.",
        "abstract": "objective study assess suitability remimazolam compared propofol general anesthesia tracheoscopic procedure patient tuberculosis undergoing treatment isoniazid retrospective analysis conducted 1098 patient diagnosed pulmonary tuberculosis underwent bronchoscopic general anesthesia institution January June 2023 Protocol No 2022LY0416 patient categorized remimazolam propofol group based primary anesthetic agent administered primary outcome assessed included time conclusion anesthesia patient awakening well hemodynamic change anesthesia period time drug withdrawal awakening significantly shorter remimazolam group compared propofol group 380 vs 1000 s P  0001 Additionally time extubation reduced remimazolam group 885 vs 1810 s P  0001 although time induction anesthesia longer postanesthesia Aldrete score higher remimazolam group propofol group P  0001 finding consistently observed subgroup analyses anesthesia maintenance amount intraoperative vasoactive drug dopamine nicardipine administered patient remimazolam group lower propofol group P  0014 P  0031 respectively Furthermore anesthesia blood pressure remimazolam group higher stable exhibiting smaller fluctuation compared propofol group Specifically change systolic blood pressure 382 ± 159 mmHg remimazolam group compared 467 ± 190 mmHg propofol group P  0001 change diastolic blood pressure 64 ± 164 mmHg remimazolam group versus 127 ± 187 mmHg propofol group P  0002 patient tuberculosis undergoing treatment isoniazid general anesthesia remimazolam associated shorter time cessation anesthesia recovery reduced requirement vasoactive agents improved hemodynamic stability without increase postoperative complications compared propofol",
        "mesh_terms": [
            "Humans",
            "Retrospective Studies",
            "Male",
            "Female",
            "Middle Aged",
            "Anesthesia, General",
            "Propofol",
            "Bronchoscopy",
            "Isoniazid",
            "Adult",
            "Benzodiazepines",
            "Antitubercular Agents",
            "Tuberculosis, Pulmonary",
            "Cohort Studies",
            "Anesthetics, Intravenous",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783679/",
        "source_type": "Global"
    },
    {
        "pmid": "40783556",
        "title": "Prevalence and types of medication errors in pro re nata medication orders among hospitalized patients: a cross-sectional study.",
        "abstract": "Medication error Pro Nata PRN prescription pose significant threat hospital settings especially due unclear prescribing practices Despite growing attention patient safety documentation PRN order remains poor increasing risk medication error adverse drug events assess prevalence type PRN medication error hospitalized patients identify highrisk drugs explore factor linked prescribing errors crosssectional study conducted 2023 Educational Research Hospital included 400 hospitalized patient received least one PRN prescription Data collected using standardized extraction form based clinical guideline expert consultation Chisquare test logistic regression used evaluate error trend associated risk factors total 741 PRN prescription lacked documented indication 911 recorded dosage interval Pethidine 326 frequently prescribed PRN medication Surgical ICU showed significantly higher number error p  005 Major predictor PRN error included missing dosage interval admission highdependency wards high frequency PRN prescribing error underscore urgent need improved documentation targeted training Structured intervention electronic prescribing focused medical education help reduce error improve patient safety Structured intervention electronic prescribing regulatory enforcement focused medical education help reduce error improve patient safety",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783556/",
        "source_type": "Global"
    },
    {
        "pmid": "40783500",
        "title": "Generalized linear modeling of flow cytometry data to analyze immune responses in tuberculosis vaccine research.",
        "abstract": "Tuberculosis TB caused Mycobacterium tuberculosis Mtb kill 13 million people annually Accordingly vaccine sophisticated analytical tool necessary evaluate effectiveness address challenges created Generalized Linear Model GLM framework evaluate highdimensional flow cytometry data multivariable influence immune responses accommodating proportional nonnormal data violation assumption set classical statistical evaluations naïve mouse vaccinated BCG boosted ID93GLASE used GLMs assess impact sex vaccination day postinfection probability immune cell phenotype following Mtb challenge demonstrate enhanced cell response lung following BCG  ID93GLASE compared BCG ID93GLASE alone notable sex difference humoral immunity framework highlight GLMs assessing complex datasets enhancing comprehension independent continuous categorical variable vaccine efficacy serf foundation deeper complex scenarios",
        "mesh_terms": [
            "Animals",
            "Mice",
            "Tuberculosis Vaccines",
            "Mycobacterium tuberculosis",
            "Flow Cytometry",
            "Female",
            "Tuberculosis",
            "Male",
            "Linear Models",
            "BCG Vaccine",
            "T-Lymphocytes",
            "Lung"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783500/",
        "source_type": "Global"
    },
    {
        "pmid": "40783398",
        "title": "High-fat and low-fiber diet elevates the gut resistome: a comparative metagenomic study.",
        "abstract": "Antimicrobial resistance AMR global health challenge gut microbiome major reservoir AMR influenced dietary habits However specific impact dietary pattern gut resistome remains poorly understood study aimed assess effect highfatlowfiber highfiberlowfat diet development AMR gut microbiome shift normal diet highfatlowfiber highfiberlowfat diet mouse resulted corresponding increase decrease relative abundance resistome 014 025 p  0001 vs 014 009 p  005 virulence gene VGs 056 091 p  0001 vs 058 050 p  005 mobile genetic element MGEs 020 166 p  0001 vs 022 013 p  005 respectively Network analysis identified bacteria Bacteroides Parabacteroides Alistipes host ARGs VGs change abundance closely associated shift ARG VG levels Mobile genetic element Tn916 ISBf10 IS91 intl1 linked variations including gene conferring resistance vancomycin capsulerelated VGs humans similar trend observed highfat diet correlating higher resistome levels highfiber diet associated lower resistome level compared normal diet group ARGs prevalent pathogenic genus Enterococcus spp Klebsiella spp Pseudomonas spp Staphylococcus spp highfatlowfiber diet increased bacterial resistome VG abundance compared highfiberlowfat diet Therefore adopting highfiberlowfat diet may effective strategy reduce AMR burden human gut providing valuable insight public health recommendations",
        "mesh_terms": [
            "Gastrointestinal Microbiome",
            "Animals",
            "Dietary Fiber",
            "Diet, High-Fat",
            "Mice",
            "Bacteria",
            "Metagenomics",
            "Male",
            "Humans",
            "Anti-Bacterial Agents",
            "Feces",
            "Interspersed Repetitive Sequences",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783398/",
        "source_type": "Global"
    },
    {
        "pmid": "40782768",
        "title": "Re-visiting the surgical role in treating chemotherapeutic-resistance pulmonary tuberculosis: Results from a systematic review and meta-analysis.",
        "abstract": "incidence prevalence multidrugresistant extensively drugresistant pulmonary tuberculosis increasing posing profound health concerns therefore surgical intervention gaining popularity again However effectiveness surgical treatment need reassessed study attempted determine efficacy surgical treatment chemotherapy compared chemotherapy alone among patient pulmonary tuberculosis systematic search metaanalysis conducted inception June 2025 existing databases including PubMed EMBASE Cochrane Central Register Controlled Trials Google Scholar doublearm study available English published 2005 August 2019 included Among 618 studies 468 selected based abstract review Eight 468 8468 study doublearm retrospective cohort observational studies included 1929 person matched inclusion criteria measure success surgical intervention used pooled rate ratio loss patient followup incidence mortality using random effect heterogeneity model Overall statistically significant difference treatment success rate RR124 098156 p  007 mortality rate RR182 0311063 p  051 two groups Interestingly summary rate ratio RR041 018093 p  003 showed surgical group considerably lower loss rate followup nonsurgical group evidence heterogeneity amongst trial I2 0  τ2 000 df2 p  036 current metaanalysis first use factor loss followup collected several report predictive tool assess effectiveness surgical participation treating drugresistant tuberculosis patients rate patient loss followup surgical group suggested combination approach surgery chemotherapy showed potential superiority chemotherapy alone",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782768/",
        "source_type": "Global"
    },
    {
        "pmid": "40782767",
        "title": "Adherence to tuberculosis infection treatment and its impact on prevention of tuberculosis reactivation: A retrospective cohort study from Taiwan.",
        "abstract": "Treatment tuberculosis infection TBI often discontinued owing adverse drug effects impact treatment completion TB reactivation remains poorly understood conducted retrospective analysis 1432 patient one medical centre Taiwan 2016 2021 Patients TBI divided three groups noninitiation N incomplete treatment IC complete treatment C exposure TB without TBI formed control group TB reactivation analysed using multivariable Cox regression models followup three years overall TB reactivation rate 23  341432 ranging 61  TBI N group n  378 21  TBI IC group n  330 05  TBI C group n  430 07  control group n  294 TBI treatment independently associated reduced risk TB reactivation adjusted hazard ratio aHR TBI IC versus TBI N 032 95  CI 012085 p  0022 TBI C versus TBI N aHR 005 95  CI 001029 p  0001 10  increase treatment adherence rate resulted 23  reduction risk TB reactivation aHR 077 95  CI 067088 p  0001 TBI treatment prescribed 67  completed 38  patients significantly reduces TB reactivation risk especially high adherence Enhancing adherence particularly among elderly patient comorbidities crucial improving effectiveness TBI treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782767/",
        "source_type": "Global"
    },
    {
        "pmid": "40782457",
        "title": "Type 1 inflammatory choroidal neovascular membrane in a case of viral uveitis - a case report.",
        "abstract": "Inflammatory type 1 CNVM severe uncommon complication associated posterior uveitis report case type 1 CNVM 50yearold man documented history viral ocular infection Although inflammatory CNVM frequently associated posterior uveitis due tuberculosis toxoplasmosis occurrence secondary viral uveitis rare patients medical history included fever followed viral conjunctivitis accompanied superficial punctate keratopathy undergoing treatment elsewhere Despite treatment continued experience pain redness photophobia metamorphopsia Upon presentation centreone month following initial symptoms diagnosis posterior uveitis CNVM established detected prior ophthalmological examinations subsequent administration intravitreal antiVEGF agent along oral corticosteroid resulted dramatic resolution CNVM best knowledge similar case started viral conjunctivitis anterior uveitis later progressed posterior uveitis type 1 CNVM reported till date Inflammatory cell released uveitis lead breakage BruchsRPE complex lead CNVM proper consensus treating inflammatory CNVMA combination intravitreal antiVEGF agent intravitreal steroid oral steroid tried various studies Unilateral CNVM developed within one month following episode posterior uveitis initially presented viral conjunctivitis Early recognition timely management intravitreal antiVEGF therapy combined systemic corticosteroid resulted favorable visual outcome recurrence observed followup period",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782457/",
        "source_type": "Global"
    },
    {
        "pmid": "40782406",
        "title": "Anti-Mycobacterium tuberculosis activity of 17-hydroxy-jolkinolide B by interacting with RNA polymerase.",
        "abstract": "Euphorbia fischeriana traditionally used Chinese medicine tuberculosis TB treatment since ancient times study first report identification abietanetype diterpenoid 17hydroxyjolkinolide B HJKB E fischeriana exhibit potent antimycobacterial activity Mycobacterium tuberculosis H37Ra strain clinical isolates minimum inhibitory concentration MICs HJKB diverse M tuberculosis strain range 1 12 μgmL Notably HJKB demonstrates significant bactericidal activity intracellular M tuberculosis H37Ra macrophage models accompanied antiinflammatory effect concentration 25 μgmL Using combination chemoproteomic analysis pulldown assays explored preliminary antimycobacterial mechanism HJKB Results indicate HJKB interacts target protein RpoB RpoC M tuberculosis H37Ra finding corroborated molecular docking studies RpoB RpoC essential subunit DNAdirected RNA polymerase holoenzyme critical bacterial ribosomal transcription regulation summary HJKB represents bioactive constituent E fischeriana antiTB efficacy acting transcription inhibitor M tuberculosis study elucidates antimycobacterial mechanism also provides preclinical foundation development natural productbased TB therapeutics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782406/",
        "source_type": "Global"
    }
]